Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see your browser settings for this feature.

lipids

Topics: nanolipds, lipds, vaccines

Collection: opensource

Language: English

some papers & documents about lipids mainly about those who are used for the so called "COVID-19 vaccines" which are per definition not vaccines but gene therapy products.

On the top left of this page below the internet archive icon you can find the "Volumes icon". If you click on the "Volumes icon" a tab on the left side opens. Within this tab you can scroll through the literature.

Oben links auf dieser Seite, unter dem Internet-Archiv-Symbol, finden Sie das "Volumes-Symbol". Wenn Sie auf das "Volumes icon" klicken, öffnet sich eine Registerkarte auf der linken Seite. Innerhalb dieser Registerkarte können Sie durch die Literatur blättern.

Addeddate: 2022-01-07 07:55:34

Identifier: lipids

Identifier-ark: ark:/13960/s2h21fd8vv5

Ocr: tesseract 5.3.0-6-g76ae

Ocr_detected_lang: en

Ocr_detected_lang_conf: 1.0000

Ocr_detected_script: Latin

Ocr_detected_script_conf: 1.0000

Ocr_module_version: 0.0.21

Ocr_parameters: -l eng

Page_number_confidence: 84

Page_number_module_version: 1.0.3

plus-circle Add Review

comment
Reviews

There are no reviews yet. Be the first one to write a review.

6,837 Views

2 Favorites

DOWNLOAD OPTIONS

132 files

CHOCR

BACK

3.0K

0000-lipid-nanoparticles_chocr.html.gz

357.8K

1989-08_cationic_liposome-mediated_RNA_transfection-6077.full_chocr.html.gz

390.9K

2005-02_the role_of_plasmid_constructs_containing_the_SV40_DNA_nuclear-targeting_sequence_in_cationic_lipid-mediated_DNA_delivery (Circular and Molecular Biology Letters - Vol10_p203_chocr.html.gz

696.7K

2006-04-14_toxicity_of_cationic_lipids_and_cationic_polymers_in_gene_delivery-journal of controlled release-markiert_chocr.html.gz

650.0K

2007-08_Cationic_lipids_used_in_non-viral_gene_delivery_systems-article1381164572_Uddin_chocr.html.gz

375.6K

2008_Nanotechnologie_in_Arzneimitteln_und_Medizinprodukten-Bruno Gander-Institute of Pharmaceutical Sciences-ETH Zürich_chocr.html.gz

604.8K

2010-06-11_the_systemic_toxicity_of_positively_charged _lipid_nanoparticles_and_the_role_of_Toll-like_receptor_4_in_immune_activation_chocr.html.gz

1.0M

2011-02_nanoparticulate_drug_delivery_in_pregnancy_placental_passage_and_fetal_exposure_chocr.html.gz

685.4K

2011_transport_of_nanoparticles_through_the_placental_barrier_chocr.html.gz

621.1K

2012-02-21_accumulation_of_nanocarriers_in_the_ovary-a_neglected_toxicity_risk_chocr.html.gz

900.9K

2012-10-18_composite_magnetic_nanoparticle_drug_delivery_system-US-Patent_20120265001A1_chocr.html.gz

2.1M

2014-01_emerging_research_and_clinical_developement_trends_of_liposome_and_lipid_nanoparticle_drug_delivery_systems-nihms-577214_chocr.html.gz

1.8M

2014-09-19_mRNA-based_therapeutics-developing_a_new_class_of_drugs-Sahin2014mRNAreview_chocr.html.gz

14.7M

2014_advances_in_genetics-non_viral_vectors_for_gene_therapy-lipid- and_polymer-based_gene_transfer-volume 88-Huang, Leaf_ Liu, Dexi_ Wagner, Ernst - Academic Press,Elsevier_chocr.html.gz

3.7M

2014_nanoparticles_and_the_immune_system-safety_and_effects-Diana Boraschi and Albert Duschl (Eds.)-Academic Press_chocr.html.gz

1.3M

2015-03_engeneering_of_lipid_nanoparticles_for_advanced_drug_delivery_chocr.html.gz

9.4M

2015_non-viral_vectors_for_gene_therapy-physical_methods_and_medical_translation, Volume 89-Academic Press - Advances in Genetics - Leaf Huang, Dexi Liu, Ernst Wagner_chocr.html.gz

1.6M

2016-08-11_lipid_nanoparticles_and_uses_thereof-patent_WO2016123864A1_chocr.html.gz

864.1K

2016-08-31_lipid_nanoparticles_for_gene_delivery-nihms812782_chocr.html.gz

419.4K

2016-09-13_Ego,_ambition,_and_turmoil-Inside_one_of_biotech's_most_secretive_startups-Statnews_chocr.html.gz

1.7M

2016-10-31_toxicity_of_graphene-family_nanoparticles-a_general_review_of_the_origins_and_mechanisms_chocr.html.gz

908.3K

2016_nanoparticle_transport_across_the_placental_barrier-pushing_the_field_forward_chocr.html.gz

5.0M

2017-05_development_and_characterization_of_microencapsulated_nanoparticle_systems_for_oral_vaccination_by_Protein-Antigens-Dissertation_chocr.html.gz

574.7K

2017-07_lipid_nanoparticle_systems_for_enabling_gene_therapies_chocr.html.gz

424.8K

2018-04-05_correlation_of_the_cytotoxic_effects_of_cationic_lipids_with_their_headgroups_chocr.html.gz

1.0M

2018-04-11_potential_adverse_effects_of_nanoparticles_in_the_reproductive_system-ijn-170723_chocr.html.gz

732.6K

2018-06-06_a_novel_amino_lipid_series_for_mRNA_delivery-improved_endosomal_escape_and_sustained_pharmacology_and_safety_in_non-human_primates_chocr.html.gz

231.6K

2018-1-16_liposomes_and_lipid_nanoparticles_as_delivery_vehicles_for_personalized_medicine_chocr.html.gz

119.6K

2019-01-08_gene_therapy_in_the_era_of_nanotechnology-a_review_of_current_data-JCPCR-10-00380_chocr.html.gz

1.0M

2019-046-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_chocr.html.gz

1.1M

2019-05-07_lipid_nanoparticles_for_deliveery_of_therapeutic_RNA_oligonucleotides-moss2019_chocr.html.gz

1.0M

2019-06-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_chocr.html.gz

759.5K

2019-08-09_Lipid_Nanoparticle_Technology_for_Clinical_Translation_of_siRNA_Therapeutics-Kulkarni et al-markiert_chocr.html.gz

87.7K

2019-08-27_biologisches_Gefahrenpotenzial_von_Nanopartikeln_untersucht_chocr.html.gz

37.6K

2020-01-05_Lipid_Nanoparticles_in_COVID-19_vaccines-letter_to_Peter Marks-Aaron Siri_chocr.html.gz

2.2M

2020-02-20_nanomedicines_to_deliver_mRNA-state_of_the_art_and_future_perspectives-nanomaterials-10-00364-v2_chocr.html.gz

757.9K

2020-03-16_lipid_nanoparticle_technology_for_clinical_translation_of_siRNA_therapeutics-ar9b00368 1..10_chocr.html.gz

887.1K

2020-03-16_nanoparticles_versus_dendritic_cells_as_vehicles_to_deliver_mRNA_encoding_multipe_epitopes_for_immunotherapy-Gene_&_Cell_Therapy_chocr.html.gz

392.5K

2020-04-22_self-amplifying_RNA_SARS-CoV-2_lipid_nanoparticle_vaccine_induces_equivalent_preclinical_antibody_titers_and_viral_neutralization_to_recovered_COVID-19_patients-055608v1.full_chocr.html.gz

1.9M

2020-06-22_nanotechnology_for_COVID-19-therapeutics_and_vaccine_research-acsnano.0c04006_chocr.html.gz

30.9M

2020-07-01_repeat-dose_toxicity_study_of_three_LNP-formulated_RNA_platforms_encoding_for_viral_proteins_by_repeated_intramuscular_administration_to_Wistar_Han_rats-125742_S1_M4_4.2.3.2+38166-bioNTech_chocr.html.gz

2.1M

2020-07-02_lipid_nanoparticle_technology_for_therapeutic_gene_regulation_in_the_liver-1-s2.0-S0169409X20300727-main_chocr.html.gz

852.8K

2020-07-03_a_brief_review_on_solid_lipid_nanoparticles-part_and_parcel_of_contemporary_drug_delivery_system-d0ra03491f_chocr.html.gz

140.8K

2020-07-16_nano_drugs-let_the_blood-brain_barrier_no_longer_be_a_barrier-biopharma PEG_chocr.html.gz

126.9K

2020-08-04_liposomes_vs. _lipid_nanoparticles-which_is_best_for_drug_delivery-biopharma PEG_chocr.html.gz

1.2M

2020-10-23_advances_in_lipid_nanoparticles_for_mRNA-based_cancer_immunotherapy-fchem-08-589959_chocr.html.gz

1.9M

2020-10-30_solid_lipid_nanoparticles_for_drug_delivery-pharmacological_and_biopharmaceutical_aspects-fmolb-07-587997_chocr.html.gz

1.5M

2020-11-09_a_tissue_distribution_study_of_a_H3-labelled_lipid_nanoparticle-mRNA_formulation_containing_ALC-0315_and_ALC-0159_following_intramuscular_administration_in_Wistar_Han_Rats-125742_S1_M4_4223_185350_chocr.html.gz

275.7K

2020-11-16_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v1_02_nr-1_chocr.html.gz

3.5M

2020_exocomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_chocr.html.gz

3.5M

2020_exosomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_chocr.html.gz

1.2M

2021-01-13_ionizable_lipid_nanoparticles_for_in_utero_mRNA_delivery-sciadv.aba1028_chocr.html.gz

1.6M

2021-01-20_saudi_medicinal_assessment_report-Pfizer-BioNTech_COVID-19_Vaccine_chocr.html.gz

1.5M

2021-02-02_lipid_nanoparticles_as_delivery_systems_for_RNA-based_vaccines-pharmaceutics-13-00206-v3_chocr.html.gz

74.5K

2021-02-09_Lipidnanopartikel_in_COVID-19-Impfung-PEG_und _ihr _allergenes_Potenzial_in_Impfstoffen_chocr.html.gz

102.6K

2021-02-11_Nanopartikel_in_mRNA-Impfstoffen-PTAheute_chocr.html.gz

27.0K

2021-02-11_SM-102_amino_lipid_product_information_chocr.html.gz

3.0M

2021-02-12_Comirnaty-report_on_the_deliberation_results-pharmaceutical_evaluatiob_division_chocr.html.gz

1.8M

2021-02-13_nanomedicine_for_COVID-19_the_role_of_nanotechnology_in_the_treatment_and_diagnosis_of_COVID-19_chocr.html.gz

122.2K

2021-03-04_editorial-lipid_nanoparticles_as_a_novel_strategy_to_deliver_bioactive_molecules_chocr.html.gz

280.8K

2021-03-06_without_these_lipid_shells,_there_would_be_no_mRNA_vaccines_for_COVID-19_chocr.html.gz

564.1K

2021-03_Vaccine_development_for_coronavirus_SARS-CoV-2_disease-lipid_nanoparticles-IJRSI_chocr.html.gz

719.5K

2021-04-03_the_mRNA-LNP_platform’s_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory_chocr.html.gz

1.6M

2021-04-08_lipd-based_nanoparticles_in_the_clinic_and_clinical_trials_from_cancer_nanomedicine_to_COVID-19_vaccines-09-00359_chocr.html.gz

461.0K

2021-04-11_Nanotechnologie_der_Covid-19-Vakzinen-Pharmazeutische Zeitung_chocr.html.gz

449.7K

2021-04-24_future_considerations_for_the_mRNA-lipid_nanoparticle_vaccine_platform_chocr.html.gz

869.1K

2021-05-18_impact_of_lipid_nanparticle_size_on_mRNA_vaccine_immunogenicity-1-s2.0-S0168365921002376-main_chocr.html.gz

806.0K

2021-05-28_antiphospholipid_antibodies_and_risk_of_post-COVID-19_vaccination_thrombophilia-The_straw_that_breaks_the_camel’s_back_chocr.html.gz

131.6K

2021-05-28_wie_gefährlich_sind_Lipidnanopartikel_in_mRNA-Impfstoffen-schiftl_Anfrage_bayerischer_Landtag-18_0016664_chocr.html.gz

306.8K

2021-06-02_gene_therapy_avenues_and_COVID-19-vaccines-s41435-021-00136-6_chocr.html.gz

2.6M

2021-06-04_COVID-19_mRNA_Vaccine_BNT162b2_UKPAR_PFIZER_BIONTECH_ext_of_indication_chocr.html.gz

134.1K

2021-06-11_overview_of_mRNA-lipid_nanoparticle_covid-19_vaccines-biopharma-PEG_chocr.html.gz

62.2K

2021-06-14_Protein_Nanopartikel_Vakzine-BG-Kliniken_chocr.html.gz

2.1M

2021-06-28_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_chocr.html.gz

36.4K

2021-07-23_ALC-0159-lipid-N-2010_TDS_rev1_chocr.html.gz

36.9K

2021-07-23_ALC-0315-lipid-N-1020_TDS_rev1a_chocr.html.gz

33.2K

2021-07-30_Lipid_Nanopartikel_ALC-0159_product_information-item_number_34336_chocr.html.gz

1.1M

2021-08-11_ionization_and_structural_properties_of_mRNA_lipid_nanoparticles_influence_expression_in_intramuscular_and_intravascular_administration-s42003-021-02441-2_chocr.html.gz

172.6K

2021-08-24_ALC-0159_Lipid-Nanopartikel-saety_data_sheet-34336m_chocr.html.gz

1.2M

2021-08_novel_lipid_nanoparticle_provides_potent_SARS-CoV2_mRNA _vaccine_at_low_dose_with_low_local_reactogenicity,_high_thermostability_and_limited_systemic_biosdistribution_chocr.html.gz

271.4K

2021-09-15_SM-102_amino_lipid_safety_data_sheet_chocr.html.gz

166.2K

2021-10-09_lipid_nanoparticles_for_drug_and_vaccine_delivery-Biopharma PEG_chocr.html.gz

1.6M

2021-10-26_lipid_nanoparticle_drug_delivery_systems-recent_advances_in_the_treatment_of_skin_disorders-pharmaceuticals-14-01083-v2_chocr.html.gz

980.5K

2021-11-08_summary_basis_for_regulatory_action-Comirnaty_chocr.html.gz

327.1K

2021-12-07_Pfizer_safety_data_sheet-PF00092-lipid_nanoparticles_MTR_PFEM_EN_chocr.html.gz

312.2K

2021-12-14_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v2 (104a-pf00161-mtr-pfem-en-002)_chocr.html.gz

340.7K

2021-12-17_potential_implications_of_lipid_nanoparticles_in_the_pathogenesis_of_myocarditis_associated_with_the_use_of_mRNA_vaccines_against_SARS-CoV-2-1-s2.0-S2589936821000839-main_chocr.html.gz

893.5K

2021-12-17_the_mRNA-LNP_platform's_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory-CellPress-article_chocr.html.gz

1.0M

2021-12-27_Rechtsgutachten_zur_Strafbarkeit_der_Impfung_nach_95 AMG-Beate Bahner_chocr.html.gz

68.6K

2021-12_lasting_impact_of_lipid_nanoparticles-s41578-021-00398-6_chocr.html.gz

1.5M

2021-12_lipid_nanoparticles_for_mRNA_delivery-review-s41578-021-00358-0_chocr.html.gz

177.9K

2021-12_replication_of_SARS-CoV-2_in_adipose_tissue_determines_organ_and_systemic_lipid_metabolism_in_hamsters_and_humans-1-s2.0-S1550413121006215-main_chocr.html.gz

49.8K

2021-BioNTech_factsheet_BNT162b2_manufacturing_process_&_ingredients_chocr.html.gz

629.9K

2022-01-08_Anti-PEG_antibodies_boosted_in_humans_by_SARS-CoV-2_lipid_nanoparticle_mRNA_vaccine-22268953v1.full_chocr.html.gz

730.5K

2022-01-11_non-viral_delivery_of_RNA_gene_therapy_to_the_central_nervous_system-Hauck-JournalArticle-2022_chocr.html.gz

169.4K

2022-01-16_Lipid_Nanoparticles_kill_80_percent_of_mice_in_PubMed_Study-thedesertreview_chocr.html.gz

521.3K

2022-01-26_biodistribution_and_non-linear_gene_expression_of_mRNA_LNPs_affected_by_delivery_route_and_particle_size_chocr.html.gz

228.2K

2022-02-16_BIONTECH_Antwort_an_Pathologie-Konferenz_chocr.html.gz

1.2M

2022-02-28_complaint_lawsuit_against_Moderna_for_patent_infringement-lipid_nanoparticles_chocr.html.gz

1.5M

2022-05-09_the_clinical_progress_of_mRNA_vaccines_and_immunotherapies-s41587-022-01294-2_chocr.html.gz

124.2K

2022-05-19_why_lipid_nanoparticles_are_the_future_of_gene_therapy_and_what_needs_to_happen_next_chocr.html.gz

2.9M

2022-05-24_lipid_nanoparticle_compositions_and_methods_for_mRNA_delivery-patent_no_11-338-044-B2_chocr.html.gz

1.4M

2022-07-03_the_role_of_lipid_components_in_lipid_nanoparticles_for_vaccines_and_gene_therapy_chocr.html.gz

573.7K

2022-07_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.)_chocr.html.gz

1.1M

2022-09-02_pre-exposure_to_mRNA-LNP_inhibits_adaptive_immune_responses_and_alters_innate_immune_fitness_in_an_inheritable_fashion-journal.ppat.1010830_chocr.html.gz

810.4K

2022-09-09_psychotropic_drugs_interaction_with_the_lipid_nanoparticle_of_COVID-19_mRNA_therapeutics-fphar-13-995481_chocr.html.gz

996.8K

2022-10_delivery_of_RNAs_to_specific_organs_by_lipid_nanoparticles_for_gene_therapy-pharmaceutics-14-02129_chocr.html.gz

1.1M

2022-12-22_lipid_nanoparticle_composition_drives_mRNA_delivery_to_the_placenta-521490v1.full_chocr.html.gz

583.5K

2022_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.) - Beste Gruesse_chocr.html.gz

477.3K

2023-01-02_relative_lethality_of_covid-19_vaccines-who_is_measuring_the_casualties-Geoff Pain PhD_chocr.html.gz

1.2M

2023-01-26_chemical-physical_criticality_and_toxicological_potential_of_lipid_nanomaterials_contained_in_a_COVID-19_mRNA_vaccine_chocr.html.gz

130.1K

2023-02-24_biontech-impfstoff_kein polydispersitätstest_vom paul-ehrlich-Berliner Zeitung_chocr.html.gz

80.5K

2023-03-02_lipid_nanoparticles_highly_effective_in_gene_therapy-Hokkaido University_chocr.html.gz

1.0M

2023-03-08_ionizable_lipid_nanoparticles_for_in_vivo_mRNA_delivery_to_the_placenta_during_pregnancy-nihms-1878359_chocr.html.gz

2.1M

2023-04-01_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_chocr.html.gz

641.0K

2023-10-23_apparent_cytotoxicity_and_intrinsic_cytotoxitiy_of_lipid_nanomaterials_contained_in_a_COVID-19-mRNA_vaccine-07102023_R1-4_chocr.html.gz

25.9M

Gene_Therapy-tools_and_potential_applications-Francisco Martin Molina_chocr.html.gz

120.6K

LP0008-LNO-0315-material_safety_data_sheet-msds-LP008.-for_research_use_only_chocr.html.gz

10.6K

LP002-ALC-0315-lipid_nanoparticle-for_research_use_only_chocr.html.gz

120.4K

LP002-ALC-0315-material_safety_data_sheet_chocr.html.gz

12.4K

LP003-ALC-0159-PEG-lipid_conjugate-for_research_use_only_chocr.html.gz

120.4K

LP003-ALC-0159_material_safety_data_sheet-msds-LP003_chocr.html.gz

18.5K

LP008-LNP-0315_lipid_nanoparticle-for_research_use_only_chocr.html.gz

504.5K

Pfizer-report_Japanese-government_chocr.html.gz

1.1M

Toxicological Concerns Related to Nanoscale Drug Delivery Systems_chocr.html.gz

92.9K

Transfektion_chocr.html.gz

209.6K

biodistribution_of_Pfizer_Lipid_Nano_Particles-Byram Bridle_chocr.html.gz

71.6K

transfection-PEG_liposome_transfection-invivotransfection.com_chocr.html.gz

73.8K

transfection-in_vivo-invivotransfection.com_chocr.html.gz

75.8K

transfection-lipid-based_transfection-invivotransfection.com_chocr.html.gz

52.5K

transfection-nanoparticle_transfection-invivotransfection.com_chocr.html.gz

124.6K

what_is_cationic_lipid_transfection-thermo fisher scientific_chocr.html.gz

132 files

EPUB

BACK

0000-lipid-nanoparticles.epub

1989-08_cationic_liposome-mediated_RNA_transfection-6077.full.epub

2005-02_the role_of_plasmid_constructs_containing_the_SV40_DNA_nuclear-targeting_sequence_in_cationic_lipid-mediated_DNA_delivery (Circular and Molecular Biology Letters - Vol10_p203.epub

2006-04-14_toxicity_of_cationic_lipids_and_cationic_polymers_in_gene_delivery-journal of controlled release-markiert.epub

2007-08_Cationic_lipids_used_in_non-viral_gene_delivery_systems-article1381164572_Uddin.epub

2008_Nanotechnologie_in_Arzneimitteln_und_Medizinprodukten-Bruno Gander-Institute of Pharmaceutical Sciences-ETH Zürich.epub

2010-06-11_the_systemic_toxicity_of_positively_charged _lipid_nanoparticles_and_the_role_of_Toll-like_receptor_4_in_immune_activation.epub

2011-02_nanoparticulate_drug_delivery_in_pregnancy_placental_passage_and_fetal_exposure.epub

2011_transport_of_nanoparticles_through_the_placental_barrier.epub

2012-02-21_accumulation_of_nanocarriers_in_the_ovary-a_neglected_toxicity_risk.epub

2012-10-18_composite_magnetic_nanoparticle_drug_delivery_system-US-Patent_20120265001A1.epub

2014-01_emerging_research_and_clinical_developement_trends_of_liposome_and_lipid_nanoparticle_drug_delivery_systems-nihms-577214.epub

2014-09-19_mRNA-based_therapeutics-developing_a_new_class_of_drugs-Sahin2014mRNAreview.epub

2014_advances_in_genetics-non_viral_vectors_for_gene_therapy-lipid- and_polymer-based_gene_transfer-volume 88-Huang, Leaf_ Liu, Dexi_ Wagner, Ernst - Academic Press,Elsevier.epub

2014_nanoparticles_and_the_immune_system-safety_and_effects-Diana Boraschi and Albert Duschl (Eds.)-Academic Press.epub

2015-03_engeneering_of_lipid_nanoparticles_for_advanced_drug_delivery.epub

2015_non-viral_vectors_for_gene_therapy-physical_methods_and_medical_translation, Volume 89-Academic Press - Advances in Genetics - Leaf Huang, Dexi Liu, Ernst Wagner.epub

2016-08-11_lipid_nanoparticles_and_uses_thereof-patent_WO2016123864A1.epub

2016-08-31_lipid_nanoparticles_for_gene_delivery-nihms812782.epub

2016-09-13_Ego,_ambition,_and_turmoil-Inside_one_of_biotech's_most_secretive_startups-Statnews.epub

2016-10-31_toxicity_of_graphene-family_nanoparticles-a_general_review_of_the_origins_and_mechanisms.epub

2016_nanoparticle_transport_across_the_placental_barrier-pushing_the_field_forward.epub

2017-05_development_and_characterization_of_microencapsulated_nanoparticle_systems_for_oral_vaccination_by_Protein-Antigens-Dissertation.epub

2017-07_lipid_nanoparticle_systems_for_enabling_gene_therapies.epub

2018-04-05_correlation_of_the_cytotoxic_effects_of_cationic_lipids_with_their_headgroups.epub

2018-04-11_potential_adverse_effects_of_nanoparticles_in_the_reproductive_system-ijn-170723.epub

2018-06-06_a_novel_amino_lipid_series_for_mRNA_delivery-improved_endosomal_escape_and_sustained_pharmacology_and_safety_in_non-human_primates.epub

2018-1-16_liposomes_and_lipid_nanoparticles_as_delivery_vehicles_for_personalized_medicine.epub

2019-01-08_gene_therapy_in_the_era_of_nanotechnology-a_review_of_current_data-JCPCR-10-00380.epub

2019-046-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main.epub

2019-05-07_lipid_nanoparticles_for_deliveery_of_therapeutic_RNA_oligonucleotides-moss2019.epub

2019-06-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main.epub

2019-08-09_Lipid_Nanoparticle_Technology_for_Clinical_Translation_of_siRNA_Therapeutics-Kulkarni et al-markiert.epub

2019-08-27_biologisches_Gefahrenpotenzial_von_Nanopartikeln_untersucht.epub

2020-01-05_Lipid_Nanoparticles_in_COVID-19_vaccines-letter_to_Peter Marks-Aaron Siri.epub

2020-02-20_nanomedicines_to_deliver_mRNA-state_of_the_art_and_future_perspectives-nanomaterials-10-00364-v2.epub

2020-03-16_lipid_nanoparticle_technology_for_clinical_translation_of_siRNA_therapeutics-ar9b00368 1..10.epub

2020-03-16_nanoparticles_versus_dendritic_cells_as_vehicles_to_deliver_mRNA_encoding_multipe_epitopes_for_immunotherapy-Gene_&_Cell_Therapy.epub

2020-04-22_self-amplifying_RNA_SARS-CoV-2_lipid_nanoparticle_vaccine_induces_equivalent_preclinical_antibody_titers_and_viral_neutralization_to_recovered_COVID-19_patients-055608v1.full.epub

2020-06-22_nanotechnology_for_COVID-19-therapeutics_and_vaccine_research-acsnano.0c04006.epub

2020-07-02_lipid_nanoparticle_technology_for_therapeutic_gene_regulation_in_the_liver-1-s2.0-S0169409X20300727-main.epub

2020-07-03_a_brief_review_on_solid_lipid_nanoparticles-part_and_parcel_of_contemporary_drug_delivery_system-d0ra03491f.epub

2020-07-16_nano_drugs-let_the_blood-brain_barrier_no_longer_be_a_barrier-biopharma PEG.epub

2020-08-04_liposomes_vs. _lipid_nanoparticles-which_is_best_for_drug_delivery-biopharma PEG.epub

2020-10-23_advances_in_lipid_nanoparticles_for_mRNA-based_cancer_immunotherapy-fchem-08-589959.epub

2020-10-30_solid_lipid_nanoparticles_for_drug_delivery-pharmacological_and_biopharmaceutical_aspects-fmolb-07-587997.epub

2020-11-16_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v1_02_nr-1.epub

2020_exocomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01.epub

2020_exosomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01.epub

2021-01-13_ionizable_lipid_nanoparticles_for_in_utero_mRNA_delivery-sciadv.aba1028.epub

2021-01-20_saudi_medicinal_assessment_report-Pfizer-BioNTech_COVID-19_Vaccine.epub

2021-02-02_lipid_nanoparticles_as_delivery_systems_for_RNA-based_vaccines-pharmaceutics-13-00206-v3.epub

2021-02-09_Lipidnanopartikel_in_COVID-19-Impfung-PEG_und _ihr _allergenes_Potenzial_in_Impfstoffen.epub

2021-02-11_Nanopartikel_in_mRNA-Impfstoffen-PTAheute.epub

2021-02-11_SM-102_amino_lipid_product_information.epub

2021-02-12_Comirnaty-report_on_the_deliberation_results-pharmaceutical_evaluatiob_division.epub

2021-02-13_nanomedicine_for_COVID-19_the_role_of_nanotechnology_in_the_treatment_and_diagnosis_of_COVID-19.epub

2021-03-04_editorial-lipid_nanoparticles_as_a_novel_strategy_to_deliver_bioactive_molecules.epub

2021-03-06_without_these_lipid_shells,_there_would_be_no_mRNA_vaccines_for_COVID-19.epub

2021-03_Vaccine_development_for_coronavirus_SARS-CoV-2_disease-lipid_nanoparticles-IJRSI.epub

2021-04-03_the_mRNA-LNP_platform’s_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory.epub

2021-04-08_lipd-based_nanoparticles_in_the_clinic_and_clinical_trials_from_cancer_nanomedicine_to_COVID-19_vaccines-09-00359.epub

2021-04-11_Nanotechnologie_der_Covid-19-Vakzinen-Pharmazeutische Zeitung.epub

2021-04-24_future_considerations_for_the_mRNA-lipid_nanoparticle_vaccine_platform.epub

2021-05-18_impact_of_lipid_nanparticle_size_on_mRNA_vaccine_immunogenicity-1-s2.0-S0168365921002376-main.epub

2021-05-28_antiphospholipid_antibodies_and_risk_of_post-COVID-19_vaccination_thrombophilia-The_straw_that_breaks_the_camel’s_back.epub

2021-05-28_wie_gefährlich_sind_Lipidnanopartikel_in_mRNA-Impfstoffen-schiftl_Anfrage_bayerischer_Landtag-18_0016664.epub

2021-06-02_gene_therapy_avenues_and_COVID-19-vaccines-s41435-021-00136-6.epub

2021-06-04_COVID-19_mRNA_Vaccine_BNT162b2_UKPAR_PFIZER_BIONTECH_ext_of_indication.epub

2021-06-11_overview_of_mRNA-lipid_nanoparticle_covid-19_vaccines-biopharma-PEG.epub

2021-06-14_Protein_Nanopartikel_Vakzine-BG-Kliniken.epub

2021-06-28_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996.epub

2021-07-23_ALC-0159-lipid-N-2010_TDS_rev1.epub

2021-07-23_ALC-0315-lipid-N-1020_TDS_rev1a.epub

2021-07-30_Lipid_Nanopartikel_ALC-0159_product_information-item_number_34336.epub

2021-08-11_ionization_and_structural_properties_of_mRNA_lipid_nanoparticles_influence_expression_in_intramuscular_and_intravascular_administration-s42003-021-02441-2.epub

2021-08-24_ALC-0159_Lipid-Nanopartikel-saety_data_sheet-34336m.epub

2021-08_novel_lipid_nanoparticle_provides_potent_SARS-CoV2_mRNA _vaccine_at_low_dose_with_low_local_reactogenicity,_high_thermostability_and_limited_systemic_biosdistribution.epub

2021-09-15_SM-102_amino_lipid_safety_data_sheet.epub

2021-10-09_lipid_nanoparticles_for_drug_and_vaccine_delivery-Biopharma PEG.epub

2021-10-26_lipid_nanoparticle_drug_delivery_systems-recent_advances_in_the_treatment_of_skin_disorders-pharmaceuticals-14-01083-v2.epub

2021-11-08_summary_basis_for_regulatory_action-Comirnaty.epub

2021-12-07_Pfizer_safety_data_sheet-PF00092-lipid_nanoparticles_MTR_PFEM_EN.epub

2021-12-14_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v2 (104a-pf00161-mtr-pfem-en-002).epub

2021-12-17_potential_implications_of_lipid_nanoparticles_in_the_pathogenesis_of_myocarditis_associated_with_the_use_of_mRNA_vaccines_against_SARS-CoV-2-1-s2.0-S2589936821000839-main.epub

2021-12-17_the_mRNA-LNP_platform's_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory-CellPress-article.epub

2021-12-27_Rechtsgutachten_zur_Strafbarkeit_der_Impfung_nach_95 AMG-Beate Bahner.epub

2021-12_lasting_impact_of_lipid_nanoparticles-s41578-021-00398-6.epub

2021-12_lipid_nanoparticles_for_mRNA_delivery-review-s41578-021-00358-0.epub

2021-12_replication_of_SARS-CoV-2_in_adipose_tissue_determines_organ_and_systemic_lipid_metabolism_in_hamsters_and_humans-1-s2.0-S1550413121006215-main.epub

2021-BioNTech_factsheet_BNT162b2_manufacturing_process_&_ingredients.epub

2022-01-08_Anti-PEG_antibodies_boosted_in_humans_by_SARS-CoV-2_lipid_nanoparticle_mRNA_vaccine-22268953v1.full.epub

2022-01-11_non-viral_delivery_of_RNA_gene_therapy_to_the_central_nervous_system-Hauck-JournalArticle-2022.epub

2022-01-16_Lipid_Nanoparticles_kill_80_percent_of_mice_in_PubMed_Study-thedesertreview.epub

2022-01-26_biodistribution_and_non-linear_gene_expression_of_mRNA_LNPs_affected_by_delivery_route_and_particle_size.epub

2022-02-16_BIONTECH_Antwort_an_Pathologie-Konferenz.epub

2022-02-28_complaint_lawsuit_against_Moderna_for_patent_infringement-lipid_nanoparticles.epub

2022-05-09_the_clinical_progress_of_mRNA_vaccines_and_immunotherapies-s41587-022-01294-2.epub

2022-05-19_why_lipid_nanoparticles_are_the_future_of_gene_therapy_and_what_needs_to_happen_next.epub

2022-05-24_lipid_nanoparticle_compositions_and_methods_for_mRNA_delivery-patent_no_11-338-044-B2.epub

2022-07-03_the_role_of_lipid_components_in_lipid_nanoparticles_for_vaccines_and_gene_therapy.epub

2022-07_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.).epub

2022-09-02_pre-exposure_to_mRNA-LNP_inhibits_adaptive_immune_responses_and_alters_innate_immune_fitness_in_an_inheritable_fashion-journal.ppat.1010830.epub

2022-09-09_psychotropic_drugs_interaction_with_the_lipid_nanoparticle_of_COVID-19_mRNA_therapeutics-fphar-13-995481.epub

2022-10_delivery_of_RNAs_to_specific_organs_by_lipid_nanoparticles_for_gene_therapy-pharmaceutics-14-02129.epub

2022-12-22_lipid_nanoparticle_composition_drives_mRNA_delivery_to_the_placenta-521490v1.full.epub

2022_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.) - Beste Gruesse.epub

2023-01-02_relative_lethality_of_covid-19_vaccines-who_is_measuring_the_casualties-Geoff Pain PhD.epub

2023-01-26_chemical-physical_criticality_and_toxicological_potential_of_lipid_nanomaterials_contained_in_a_COVID-19_mRNA_vaccine.epub

2023-02-24_biontech-impfstoff_kein polydispersitätstest_vom paul-ehrlich-Berliner Zeitung.epub

2023-03-02_lipid_nanoparticles_highly_effective_in_gene_therapy-Hokkaido University.epub

2023-03-08_ionizable_lipid_nanoparticles_for_in_vivo_mRNA_delivery_to_the_placenta_during_pregnancy-nihms-1878359.epub

2023-04-01_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996.epub

2023-10-23_apparent_cytotoxicity_and_intrinsic_cytotoxitiy_of_lipid_nanomaterials_contained_in_a_COVID-19-mRNA_vaccine-07102023_R1-4.epub

Gene_Therapy-tools_and_potential_applications-Francisco Martin Molina.epub

LP0008-LNO-0315-material_safety_data_sheet-msds-LP008.-for_research_use_only.epub

LP002-ALC-0315-lipid_nanoparticle-for_research_use_only.epub

LP002-ALC-0315-material_safety_data_sheet.epub

LP003-ALC-0159-PEG-lipid_conjugate-for_research_use_only.epub

LP003-ALC-0159_material_safety_data_sheet-msds-LP003.epub

LP008-LNP-0315_lipid_nanoparticle-for_research_use_only.epub

Pfizer-report_Japanese-government.epub

Toxicological Concerns Related to Nanoscale Drug Delivery Systems.epub

Transfektion.epub

biodistribution_of_Pfizer_Lipid_Nano_Particles-Byram Bridle.epub

transfection-PEG_liposome_transfection-invivotransfection.com.epub

transfection-in_vivo-invivotransfection.com.epub

transfection-lipid-based_transfection-invivotransfection.com.epub

transfection-nanoparticle_transfection-invivotransfection.com.epub

what_is_cationic_lipid_transfection-thermo fisher scientific.epub

132 files

FULL TEXT

BACK

175.0B

0000-lipid-nanoparticles_djvu.txt

25.5K

1989-08_cationic_liposome-mediated_RNA_transfection-6077.full_djvu.txt

29.9K

2005-02_the role_of_plasmid_constructs_containing_the_SV40_DNA_nuclear-targeting_sequence_in_cationic_lipid-mediated_DNA_delivery (Circular and Molecular Biology Letters - Vol10_p203_djvu.txt

54.0K

2006-04-14_toxicity_of_cationic_lipids_and_cationic_polymers_in_gene_delivery-journal of controlled release-markiert_djvu.txt

49.4K

2007-08_Cationic_lipids_used_in_non-viral_gene_delivery_systems-article1381164572_Uddin_djvu.txt

27.0K

2008_Nanotechnologie_in_Arzneimitteln_und_Medizinprodukten-Bruno Gander-Institute of Pharmaceutical Sciences-ETH Zürich_djvu.txt

47.0K

2010-06-11_the_systemic_toxicity_of_positively_charged _lipid_nanoparticles_and_the_role_of_Toll-like_receptor_4_in_immune_activation_djvu.txt

83.6K

2011-02_nanoparticulate_drug_delivery_in_pregnancy_placental_passage_and_fetal_exposure_djvu.txt

53.3K

2011_transport_of_nanoparticles_through_the_placental_barrier_djvu.txt

46.1K

2012-02-21_accumulation_of_nanocarriers_in_the_ovary-a_neglected_toxicity_risk_djvu.txt

72.6K

2012-10-18_composite_magnetic_nanoparticle_drug_delivery_system-US-Patent_20120265001A1_djvu.txt

168.7K

2014-01_emerging_research_and_clinical_developement_trends_of_liposome_and_lipid_nanoparticle_drug_delivery_systems-nihms-577214_djvu.txt

141.4K

2014-09-19_mRNA-based_therapeutics-developing_a_new_class_of_drugs-Sahin2014mRNAreview_djvu.txt

1.1M

2014_advances_in_genetics-non_viral_vectors_for_gene_therapy-lipid- and_polymer-based_gene_transfer-volume 88-Huang, Leaf_ Liu, Dexi_ Wagner, Ernst - Academic Press,Elsevier_djvu.txt

293.1K

2014_nanoparticles_and_the_immune_system-safety_and_effects-Diana Boraschi and Albert Duschl (Eds.)-Academic Press_djvu.txt

97.6K

2015-03_engeneering_of_lipid_nanoparticles_for_advanced_drug_delivery_djvu.txt

732.4K

2015_non-viral_vectors_for_gene_therapy-physical_methods_and_medical_translation, Volume 89-Academic Press - Advances in Genetics - Leaf Huang, Dexi Liu, Ernst Wagner_djvu.txt

121.4K

2016-08-11_lipid_nanoparticles_and_uses_thereof-patent_WO2016123864A1_djvu.txt

67.6K

2016-08-31_lipid_nanoparticles_for_gene_delivery-nihms812782_djvu.txt

32.1K

2016-09-13_Ego,_ambition,_and_turmoil-Inside_one_of_biotech's_most_secretive_startups-Statnews_djvu.txt

125.3K

2016-10-31_toxicity_of_graphene-family_nanoparticles-a_general_review_of_the_origins_and_mechanisms_djvu.txt

69.7K

2016_nanoparticle_transport_across_the_placental_barrier-pushing_the_field_forward_djvu.txt

384.1K

2017-05_development_and_characterization_of_microencapsulated_nanoparticle_systems_for_oral_vaccination_by_Protein-Antigens-Dissertation_djvu.txt

44.6K

2017-07_lipid_nanoparticle_systems_for_enabling_gene_therapies_djvu.txt

30.9K

2018-04-05_correlation_of_the_cytotoxic_effects_of_cationic_lipids_with_their_headgroups_djvu.txt

84.8K

2018-04-11_potential_adverse_effects_of_nanoparticles_in_the_reproductive_system-ijn-170723_djvu.txt

56.3K

2018-06-06_a_novel_amino_lipid_series_for_mRNA_delivery-improved_endosomal_escape_and_sustained_pharmacology_and_safety_in_non-human_primates_djvu.txt

17.4K

2018-1-16_liposomes_and_lipid_nanoparticles_as_delivery_vehicles_for_personalized_medicine_djvu.txt

9.4K

2019-01-08_gene_therapy_in_the_era_of_nanotechnology-a_review_of_current_data-JCPCR-10-00380_djvu.txt

81.5K

2019-046-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_djvu.txt

85.2K

2019-05-07_lipid_nanoparticles_for_deliveery_of_therapeutic_RNA_oligonucleotides-moss2019_djvu.txt

81.5K

2019-06-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_djvu.txt

57.7K

2019-08-09_Lipid_Nanoparticle_Technology_for_Clinical_Translation_of_siRNA_Therapeutics-Kulkarni et al-markiert_djvu.txt

6.3K

2019-08-27_biologisches_Gefahrenpotenzial_von_Nanopartikeln_untersucht_djvu.txt

2.8K

2020-01-05_Lipid_Nanoparticles_in_COVID-19_vaccines-letter_to_Peter Marks-Aaron Siri_djvu.txt

170.0K

2020-02-20_nanomedicines_to_deliver_mRNA-state_of_the_art_and_future_perspectives-nanomaterials-10-00364-v2_djvu.txt

57.7K

2020-03-16_lipid_nanoparticle_technology_for_clinical_translation_of_siRNA_therapeutics-ar9b00368 1..10_djvu.txt

67.3K

2020-03-16_nanoparticles_versus_dendritic_cells_as_vehicles_to_deliver_mRNA_encoding_multipe_epitopes_for_immunotherapy-Gene_&_Cell_Therapy_djvu.txt

29.2K

2020-04-22_self-amplifying_RNA_SARS-CoV-2_lipid_nanoparticle_vaccine_induces_equivalent_preclinical_antibody_titers_and_viral_neutralization_to_recovered_COVID-19_patients-055608v1.full_djvu.txt

139.7K

2020-06-22_nanotechnology_for_COVID-19-therapeutics_and_vaccine_research-acsnano.0c04006_djvu.txt

2.6M

167.8K

2020-07-02_lipid_nanoparticle_technology_for_therapeutic_gene_regulation_in_the_liver-1-s2.0-S0169409X20300727-main_djvu.txt

66.1K

2020-07-03_a_brief_review_on_solid_lipid_nanoparticles-part_and_parcel_of_contemporary_drug_delivery_system-d0ra03491f_djvu.txt

10.8K

2020-07-16_nano_drugs-let_the_blood-brain_barrier_no_longer_be_a_barrier-biopharma PEG_djvu.txt

9.6K

2020-08-04_liposomes_vs. _lipid_nanoparticles-which_is_best_for_drug_delivery-biopharma PEG_djvu.txt

94.2K

2020-10-23_advances_in_lipid_nanoparticles_for_mRNA-based_cancer_immunotherapy-fchem-08-589959_djvu.txt

151.2K

2020-10-30_solid_lipid_nanoparticles_for_drug_delivery-pharmacological_and_biopharmaceutical_aspects-fmolb-07-587997_djvu.txt

114.5K

20.9K

2020-11-16_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v1_02_nr-1_djvu.txt

281.2K

2020_exocomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_djvu.txt

280.2K

2020_exosomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_djvu.txt

95.2K

2021-01-13_ionizable_lipid_nanoparticles_for_in_utero_mRNA_delivery-sciadv.aba1028_djvu.txt

125.8K

2021-01-20_saudi_medicinal_assessment_report-Pfizer-BioNTech_COVID-19_Vaccine_djvu.txt

115.8K

2021-02-02_lipid_nanoparticles_as_delivery_systems_for_RNA-based_vaccines-pharmaceutics-13-00206-v3_djvu.txt

5.2K

2021-02-09_Lipidnanopartikel_in_COVID-19-Impfung-PEG_und _ihr _allergenes_Potenzial_in_Impfstoffen_djvu.txt

7.4K

2021-02-11_Nanopartikel_in_mRNA-Impfstoffen-PTAheute_djvu.txt

2.0K

2021-02-11_SM-102_amino_lipid_product_information_djvu.txt

237.4K

2021-02-12_Comirnaty-report_on_the_deliberation_results-pharmaceutical_evaluatiob_division_djvu.txt

142.7K

2021-02-13_nanomedicine_for_COVID-19_the_role_of_nanotechnology_in_the_treatment_and_diagnosis_of_COVID-19_djvu.txt

9.0K

2021-03-04_editorial-lipid_nanoparticles_as_a_novel_strategy_to_deliver_bioactive_molecules_djvu.txt

20.8K

2021-03-06_without_these_lipid_shells,_there_would_be_no_mRNA_vaccines_for_COVID-19_djvu.txt

43.5K

2021-03_Vaccine_development_for_coronavirus_SARS-CoV-2_disease-lipid_nanoparticles-IJRSI_djvu.txt

54.1K

2021-04-03_the_mRNA-LNP_platform’s_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory_djvu.txt

121.4K

2021-04-08_lipd-based_nanoparticles_in_the_clinic_and_clinical_trials_from_cancer_nanomedicine_to_COVID-19_vaccines-09-00359_djvu.txt

32.6K

2021-04-11_Nanotechnologie_der_Covid-19-Vakzinen-Pharmazeutische Zeitung_djvu.txt

34.1K

2021-04-24_future_considerations_for_the_mRNA-lipid_nanoparticle_vaccine_platform_djvu.txt

66.9K

2021-05-18_impact_of_lipid_nanparticle_size_on_mRNA_vaccine_immunogenicity-1-s2.0-S0168365921002376-main_djvu.txt

62.6K

2021-05-28_antiphospholipid_antibodies_and_risk_of_post-COVID-19_vaccination_thrombophilia-The_straw_that_breaks_the_camel’s_back_djvu.txt

9.6K

2021-05-28_wie_gefährlich_sind_Lipidnanopartikel_in_mRNA-Impfstoffen-schiftl_Anfrage_bayerischer_Landtag-18_0016664_djvu.txt

24.3K

2021-06-02_gene_therapy_avenues_and_COVID-19-vaccines-s41435-021-00136-6_djvu.txt

202.3K

2021-06-04_COVID-19_mRNA_Vaccine_BNT162b2_UKPAR_PFIZER_BIONTECH_ext_of_indication_djvu.txt

10.3K

2021-06-11_overview_of_mRNA-lipid_nanoparticle_covid-19_vaccines-biopharma-PEG_djvu.txt

4.3K

2021-06-14_Protein_Nanopartikel_Vakzine-BG-Kliniken_djvu.txt

165.5K

2021-06-28_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_djvu.txt

2.6K

2021-07-23_ALC-0159-lipid-N-2010_TDS_rev1_djvu.txt

2.7K

2021-07-23_ALC-0315-lipid-N-1020_TDS_rev1a_djvu.txt

2.5K

2021-07-30_Lipid_Nanopartikel_ALC-0159_product_information-item_number_34336_djvu.txt

84.3K

2021-08-11_ionization_and_structural_properties_of_mRNA_lipid_nanoparticles_influence_expression_in_intramuscular_and_intravascular_administration-s42003-021-02441-2_djvu.txt

13.1K

2021-08-24_ALC-0159_Lipid-Nanopartikel-saety_data_sheet-34336m_djvu.txt

95.2K

2021-08_novel_lipid_nanoparticle_provides_potent_SARS-CoV2_mRNA _vaccine_at_low_dose_with_low_local_reactogenicity,_high_thermostability_and_limited_systemic_biosdistribution_djvu.txt

20.6K

2021-09-15_SM-102_amino_lipid_safety_data_sheet_djvu.txt

12.8K

2021-10-09_lipid_nanoparticles_for_drug_and_vaccine_delivery-Biopharma PEG_djvu.txt

121.7K

2021-10-26_lipid_nanoparticle_drug_delivery_systems-recent_advances_in_the_treatment_of_skin_disorders-pharmaceuticals-14-01083-v2_djvu.txt

73.4K

2021-11-08_summary_basis_for_regulatory_action-Comirnaty_djvu.txt

24.8K

2021-12-07_Pfizer_safety_data_sheet-PF00092-lipid_nanoparticles_MTR_PFEM_EN_djvu.txt

23.6K

2021-12-14_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v2 (104a-pf00161-mtr-pfem-en-002)_djvu.txt

24.9K

2021-12-17_potential_implications_of_lipid_nanoparticles_in_the_pathogenesis_of_myocarditis_associated_with_the_use_of_mRNA_vaccines_against_SARS-CoV-2-1-s2.0-S2589936821000839-main_djvu.txt

64.2K

2021-12-17_the_mRNA-LNP_platform's_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory-CellPress-article_djvu.txt

77.1K

2021-12-27_Rechtsgutachten_zur_Strafbarkeit_der_Impfung_nach_95 AMG-Beate Bahner_djvu.txt

5.3K

2021-12_lasting_impact_of_lipid_nanoparticles-s41578-021-00398-6_djvu.txt

116.4K

2021-12_lipid_nanoparticles_for_mRNA_delivery-review-s41578-021-00358-0_djvu.txt

13.6K

2021-12_replication_of_SARS-CoV-2_in_adipose_tissue_determines_organ_and_systemic_lipid_metabolism_in_hamsters_and_humans-1-s2.0-S1550413121006215-main_djvu.txt

3.5K

2021-BioNTech_factsheet_BNT162b2_manufacturing_process_&_ingredients_djvu.txt

45.5K

2022-01-08_Anti-PEG_antibodies_boosted_in_humans_by_SARS-CoV-2_lipid_nanoparticle_mRNA_vaccine-22268953v1.full_djvu.txt

55.5K

2022-01-11_non-viral_delivery_of_RNA_gene_therapy_to_the_central_nervous_system-Hauck-JournalArticle-2022_djvu.txt

12.8K

2022-01-16_Lipid_Nanoparticles_kill_80_percent_of_mice_in_PubMed_Study-thedesertreview_djvu.txt

39.8K

2022-01-26_biodistribution_and_non-linear_gene_expression_of_mRNA_LNPs_affected_by_delivery_route_and_particle_size_djvu.txt

16.9K

2022-02-16_BIONTECH_Antwort_an_Pathologie-Konferenz_djvu.txt

95.6K

2022-02-28_complaint_lawsuit_against_Moderna_for_patent_infringement-lipid_nanoparticles_djvu.txt

117.0K

2022-05-09_the_clinical_progress_of_mRNA_vaccines_and_immunotherapies-s41587-022-01294-2_djvu.txt

9.8K

2022-05-19_why_lipid_nanoparticles_are_the_future_of_gene_therapy_and_what_needs_to_happen_next_djvu.txt

234.6K

2022-05-24_lipid_nanoparticle_compositions_and_methods_for_mRNA_delivery-patent_no_11-338-044-B2_djvu.txt

115.8K

2022-07-03_the_role_of_lipid_components_in_lipid_nanoparticles_for_vaccines_and_gene_therapy_djvu.txt

44.3K

2022-07_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.)_djvu.txt

81.7K

2022-09-02_pre-exposure_to_mRNA-LNP_inhibits_adaptive_immune_responses_and_alters_innate_immune_fitness_in_an_inheritable_fashion-journal.ppat.1010830_djvu.txt

62.3K

2022-09-09_psychotropic_drugs_interaction_with_the_lipid_nanoparticle_of_COVID-19_mRNA_therapeutics-fphar-13-995481_djvu.txt

73.9K

2022-10_delivery_of_RNAs_to_specific_organs_by_lipid_nanoparticles_for_gene_therapy-pharmaceutics-14-02129_djvu.txt

86.7K

2022-12-22_lipid_nanoparticle_composition_drives_mRNA_delivery_to_the_placenta-521490v1.full_djvu.txt

44.0K

2022_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.) - Beste Gruesse_djvu.txt

37.9K

2023-01-02_relative_lethality_of_covid-19_vaccines-who_is_measuring_the_casualties-Geoff Pain PhD_djvu.txt

95.7K

2023-01-26_chemical-physical_criticality_and_toxicological_potential_of_lipid_nanomaterials_contained_in_a_COVID-19_mRNA_vaccine_djvu.txt

10.0K

2023-02-24_biontech-impfstoff_kein polydispersitätstest_vom paul-ehrlich-Berliner Zeitung_djvu.txt

5.9K

2023-03-02_lipid_nanoparticles_highly_effective_in_gene_therapy-Hokkaido University_djvu.txt

81.2K

2023-03-08_ionizable_lipid_nanoparticles_for_in_vivo_mRNA_delivery_to_the_placenta_during_pregnancy-nihms-1878359_djvu.txt

165.5K

2023-04-01_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_djvu.txt

47.6K

2023-10-23_apparent_cytotoxicity_and_intrinsic_cytotoxitiy_of_lipid_nanomaterials_contained_in_a_COVID-19-mRNA_vaccine-07102023_R1-4_djvu.txt

2.0M

Gene_Therapy-tools_and_potential_applications-Francisco Martin Molina_djvu.txt

9.2K

LP0008-LNO-0315-material_safety_data_sheet-msds-LP008.-for_research_use_only_djvu.txt

684.0B

LP002-ALC-0315-lipid_nanoparticle-for_research_use_only_djvu.txt

9.2K

LP002-ALC-0315-material_safety_data_sheet_djvu.txt

801.0B

LP003-ALC-0159-PEG-lipid_conjugate-for_research_use_only_djvu.txt

9.2K

LP003-ALC-0159_material_safety_data_sheet-msds-LP003_djvu.txt

1.3K

LP008-LNP-0315_lipid_nanoparticle-for_research_use_only_djvu.txt

36.2K

Pfizer-report_Japanese-government_djvu.txt

86.6K

Toxicological Concerns Related to Nanoscale Drug Delivery Systems_djvu.txt

7.0K

Transfektion_djvu.txt

16.1K

biodistribution_of_Pfizer_Lipid_Nano_Particles-Byram Bridle_djvu.txt

5.5K

transfection-PEG_liposome_transfection-invivotransfection.com_djvu.txt

5.7K

transfection-in_vivo-invivotransfection.com_djvu.txt

5.8K

transfection-lipid-based_transfection-invivotransfection.com_djvu.txt

4.0K

transfection-nanoparticle_transfection-invivotransfection.com_djvu.txt

10.2K

what_is_cationic_lipid_transfection-thermo fisher scientific_djvu.txt

132 files

HOCR

BACK

3.9K

0000-lipid-nanoparticles_hocr.html

611.8K

1989-08_cationic_liposome-mediated_RNA_transfection-6077.full_hocr.html

674.3K

2005-02_the role_of_plasmid_constructs_containing_the_SV40_DNA_nuclear-targeting_sequence_in_cationic_lipid-mediated_DNA_delivery (Circular and Molecular Biology Letters - Vol10_p203_hocr.html

1.1M

2006-04-14_toxicity_of_cationic_lipids_and_cationic_polymers_in_gene_delivery-journal of controlled release-markiert_hocr.html

1.0M

2007-08_Cationic_lipids_used_in_non-viral_gene_delivery_systems-article1381164572_Uddin_hocr.html

690.8K

2008_Nanotechnologie_in_Arzneimitteln_und_Medizinprodukten-Bruno Gander-Institute of Pharmaceutical Sciences-ETH Zürich_hocr.html

1.1M

2010-06-11_the_systemic_toxicity_of_positively_charged _lipid_nanoparticles_and_the_role_of_Toll-like_receptor_4_in_immune_activation_hocr.html

1.7M

2011-02_nanoparticulate_drug_delivery_in_pregnancy_placental_passage_and_fetal_exposure_hocr.html

1.1M

2011_transport_of_nanoparticles_through_the_placental_barrier_hocr.html

1.0M

2012-02-21_accumulation_of_nanocarriers_in_the_ovary-a_neglected_toxicity_risk_hocr.html

1.6M

2012-10-18_composite_magnetic_nanoparticle_drug_delivery_system-US-Patent_20120265001A1_hocr.html

3.4M

2014-01_emerging_research_and_clinical_developement_trends_of_liposome_and_lipid_nanoparticle_drug_delivery_systems-nihms-577214_hocr.html

3.0M

2014-09-19_mRNA-based_therapeutics-developing_a_new_class_of_drugs-Sahin2014mRNAreview_hocr.html

23.0M

2014_advances_in_genetics-non_viral_vectors_for_gene_therapy-lipid- and_polymer-based_gene_transfer-volume 88-Huang, Leaf_ Liu, Dexi_ Wagner, Ernst - Academic Press,Elsevier_hocr.html

6.2M

2014_nanoparticles_and_the_immune_system-safety_and_effects-Diana Boraschi and Albert Duschl (Eds.)-Academic Press_hocr.html

2.1M

2015-03_engeneering_of_lipid_nanoparticles_for_advanced_drug_delivery_hocr.html

15.4M

2015_non-viral_vectors_for_gene_therapy-physical_methods_and_medical_translation, Volume 89-Academic Press - Advances in Genetics - Leaf Huang, Dexi Liu, Ernst Wagner_hocr.html

2.7M

2016-08-11_lipid_nanoparticles_and_uses_thereof-patent_WO2016123864A1_hocr.html

1.3M

2016-08-31_lipid_nanoparticles_for_gene_delivery-nihms812782_hocr.html

684.6K

2016-09-13_Ego,_ambition,_and_turmoil-Inside_one_of_biotech's_most_secretive_startups-Statnews_hocr.html

2.7M

2016-10-31_toxicity_of_graphene-family_nanoparticles-a_general_review_of_the_origins_and_mechanisms_hocr.html

1.5M

2016_nanoparticle_transport_across_the_placental_barrier-pushing_the_field_forward_hocr.html

7.6M

2017-05_development_and_characterization_of_microencapsulated_nanoparticle_systems_for_oral_vaccination_by_Protein-Antigens-Dissertation_hocr.html

970.0K

2017-07_lipid_nanoparticle_systems_for_enabling_gene_therapies_hocr.html

757.0K

2018-04-05_correlation_of_the_cytotoxic_effects_of_cationic_lipids_with_their_headgroups_hocr.html

1.9M

2018-04-11_potential_adverse_effects_of_nanoparticles_in_the_reproductive_system-ijn-170723_hocr.html

1.3M

2018-06-06_a_novel_amino_lipid_series_for_mRNA_delivery-improved_endosomal_escape_and_sustained_pharmacology_and_safety_in_non-human_primates_hocr.html

364.4K

2018-1-16_liposomes_and_lipid_nanoparticles_as_delivery_vehicles_for_personalized_medicine_hocr.html

198.8K

2019-01-08_gene_therapy_in_the_era_of_nanotechnology-a_review_of_current_data-JCPCR-10-00380_hocr.html

1.7M

2019-046-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_hocr.html

1.8M

2019-05-07_lipid_nanoparticles_for_deliveery_of_therapeutic_RNA_oligonucleotides-moss2019_hocr.html

1.7M

2019-06-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_hocr.html

1.2M

2019-08-09_Lipid_Nanoparticle_Technology_for_Clinical_Translation_of_siRNA_Therapeutics-Kulkarni et al-markiert_hocr.html

117.7K

2019-08-27_biologisches_Gefahrenpotenzial_von_Nanopartikeln_untersucht_hocr.html

60.2K

2020-01-05_Lipid_Nanoparticles_in_COVID-19_vaccines-letter_to_Peter Marks-Aaron Siri_hocr.html

3.4M

2020-02-20_nanomedicines_to_deliver_mRNA-state_of_the_art_and_future_perspectives-nanomaterials-10-00364-v2_hocr.html

1.2M

2020-03-16_lipid_nanoparticle_technology_for_clinical_translation_of_siRNA_therapeutics-ar9b00368 1..10_hocr.html

1.6M

2020-03-16_nanoparticles_versus_dendritic_cells_as_vehicles_to_deliver_mRNA_encoding_multipe_epitopes_for_immunotherapy-Gene_&_Cell_Therapy_hocr.html

617.5K

2020-04-22_self-amplifying_RNA_SARS-CoV-2_lipid_nanoparticle_vaccine_induces_equivalent_preclinical_antibody_titers_and_viral_neutralization_to_recovered_COVID-19_patients-055608v1.full_hocr.html

3.0M

2020-06-22_nanotechnology_for_COVID-19-therapeutics_and_vaccine_research-acsnano.0c04006_hocr.html

70.3M

3.3M

2020-07-02_lipid_nanoparticle_technology_for_therapeutic_gene_regulation_in_the_liver-1-s2.0-S0169409X20300727-main_hocr.html

1.6M

2020-07-03_a_brief_review_on_solid_lipid_nanoparticles-part_and_parcel_of_contemporary_drug_delivery_system-d0ra03491f_hocr.html

230.8K

2020-07-16_nano_drugs-let_the_blood-brain_barrier_no_longer_be_a_barrier-biopharma PEG_hocr.html

215.1K

2020-08-04_liposomes_vs. _lipid_nanoparticles-which_is_best_for_drug_delivery-biopharma PEG_hocr.html

1.9M

2020-10-23_advances_in_lipid_nanoparticles_for_mRNA-based_cancer_immunotherapy-fchem-08-589959_hocr.html

3.1M

2020-10-30_solid_lipid_nanoparticles_for_drug_delivery-pharmacological_and_biopharmaceutical_aspects-fmolb-07-587997_hocr.html

3.0M

501.6K

2020-11-16_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v1_02_nr-1_hocr.html

6.1M

2020_exocomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_hocr.html

6.0M

2020_exosomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_hocr.html

2.1M

2021-01-13_ionizable_lipid_nanoparticles_for_in_utero_mRNA_delivery-sciadv.aba1028_hocr.html

2.9M

2021-01-20_saudi_medicinal_assessment_report-Pfizer-BioNTech_COVID-19_Vaccine_hocr.html

2.3M

2021-02-02_lipid_nanoparticles_as_delivery_systems_for_RNA-based_vaccines-pharmaceutics-13-00206-v3_hocr.html

99.4K

2021-02-09_Lipidnanopartikel_in_COVID-19-Impfung-PEG_und _ihr _allergenes_Potenzial_in_Impfstoffen_hocr.html

137.9K

2021-02-11_Nanopartikel_in_mRNA-Impfstoffen-PTAheute_hocr.html

45.8K

2021-02-11_SM-102_amino_lipid_product_information_hocr.html

5.4M

2021-02-12_Comirnaty-report_on_the_deliberation_results-pharmaceutical_evaluatiob_division_hocr.html

3.1M

2021-02-13_nanomedicine_for_COVID-19_the_role_of_nanotechnology_in_the_treatment_and_diagnosis_of_COVID-19_hocr.html

183.2K

2021-03-04_editorial-lipid_nanoparticles_as_a_novel_strategy_to_deliver_bioactive_molecules_hocr.html

455.1K

2021-03-06_without_these_lipid_shells,_there_would_be_no_mRNA_vaccines_for_COVID-19_hocr.html

932.1K

2021-03_Vaccine_development_for_coronavirus_SARS-CoV-2_disease-lipid_nanoparticles-IJRSI_hocr.html

1.2M

2021-04-03_the_mRNA-LNP_platform’s_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory_hocr.html

2.4M

2021-04-08_lipd-based_nanoparticles_in_the_clinic_and_clinical_trials_from_cancer_nanomedicine_to_COVID-19_vaccines-09-00359_hocr.html

615.3K

2021-04-11_Nanotechnologie_der_Covid-19-Vakzinen-Pharmazeutische Zeitung_hocr.html

752.4K

2021-04-24_future_considerations_for_the_mRNA-lipid_nanoparticle_vaccine_platform_hocr.html

1.5M

2021-05-18_impact_of_lipid_nanparticle_size_on_mRNA_vaccine_immunogenicity-1-s2.0-S0168365921002376-main_hocr.html

1.2M

2021-05-28_antiphospholipid_antibodies_and_risk_of_post-COVID-19_vaccination_thrombophilia-The_straw_that_breaks_the_camel’s_back_hocr.html

171.8K

2021-05-28_wie_gefährlich_sind_Lipidnanopartikel_in_mRNA-Impfstoffen-schiftl_Anfrage_bayerischer_Landtag-18_0016664_hocr.html

528.3K

2021-06-02_gene_therapy_avenues_and_COVID-19-vaccines-s41435-021-00136-6_hocr.html

4.5M

2021-06-04_COVID-19_mRNA_Vaccine_BNT162b2_UKPAR_PFIZER_BIONTECH_ext_of_indication_hocr.html

231.3K

2021-06-11_overview_of_mRNA-lipid_nanoparticle_covid-19_vaccines-biopharma-PEG_hocr.html

95.8K

2021-06-14_Protein_Nanopartikel_Vakzine-BG-Kliniken_hocr.html

3.5M

2021-06-28_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_hocr.html

56.7K

2021-07-23_ALC-0159-lipid-N-2010_TDS_rev1_hocr.html

55.9K

2021-07-23_ALC-0315-lipid-N-1020_TDS_rev1a_hocr.html

56.3K

2021-07-30_Lipid_Nanopartikel_ALC-0159_product_information-item_number_34336_hocr.html

1.9M

2021-08-11_ionization_and_structural_properties_of_mRNA_lipid_nanoparticles_influence_expression_in_intramuscular_and_intravascular_administration-s42003-021-02441-2_hocr.html

337.9K

2021-08-24_ALC-0159_Lipid-Nanopartikel-saety_data_sheet-34336m_hocr.html

2.2M

2021-08_novel_lipid_nanoparticle_provides_potent_SARS-CoV2_mRNA _vaccine_at_low_dose_with_low_local_reactogenicity,_high_thermostability_and_limited_systemic_biosdistribution_hocr.html

555.8K

2021-09-15_SM-102_amino_lipid_safety_data_sheet_hocr.html

276.0K

2021-10-09_lipid_nanoparticles_for_drug_and_vaccine_delivery-Biopharma PEG_hocr.html

2.5M

2021-10-26_lipid_nanoparticle_drug_delivery_systems-recent_advances_in_the_treatment_of_skin_disorders-pharmaceuticals-14-01083-v2_hocr.html

1.6M

2021-11-08_summary_basis_for_regulatory_action-Comirnaty_hocr.html

602.2K

2021-12-07_Pfizer_safety_data_sheet-PF00092-lipid_nanoparticles_MTR_PFEM_EN_hocr.html

532.9K

2021-12-14_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v2 (104a-pf00161-mtr-pfem-en-002)_hocr.html

508.4K

2021-12-17_potential_implications_of_lipid_nanoparticles_in_the_pathogenesis_of_myocarditis_associated_with_the_use_of_mRNA_vaccines_against_SARS-CoV-2-1-s2.0-S2589936821000839-main_hocr.html

1.5M

2021-12-17_the_mRNA-LNP_platform's_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory-CellPress-article_hocr.html

1.5M

2021-12-27_Rechtsgutachten_zur_Strafbarkeit_der_Impfung_nach_95 AMG-Beate Bahner_hocr.html

118.4K

2021-12_lasting_impact_of_lipid_nanoparticles-s41578-021-00398-6_hocr.html

2.5M

2021-12_lipid_nanoparticles_for_mRNA_delivery-review-s41578-021-00358-0_hocr.html

291.7K

2021-12_replication_of_SARS-CoV-2_in_adipose_tissue_determines_organ_and_systemic_lipid_metabolism_in_hamsters_and_humans-1-s2.0-S1550413121006215-main_hocr.html

91.4K

2021-BioNTech_factsheet_BNT162b2_manufacturing_process_&_ingredients_hocr.html

1,010.4K

2022-01-08_Anti-PEG_antibodies_boosted_in_humans_by_SARS-CoV-2_lipid_nanoparticle_mRNA_vaccine-22268953v1.full_hocr.html

1.2M

2022-01-11_non-viral_delivery_of_RNA_gene_therapy_to_the_central_nervous_system-Hauck-JournalArticle-2022_hocr.html

248.7K

2022-01-16_Lipid_Nanoparticles_kill_80_percent_of_mice_in_PubMed_Study-thedesertreview_hocr.html

898.5K

2022-01-26_biodistribution_and_non-linear_gene_expression_of_mRNA_LNPs_affected_by_delivery_route_and_particle_size_hocr.html

320.2K

2022-02-16_BIONTECH_Antwort_an_Pathologie-Konferenz_hocr.html

2.0M

2022-02-28_complaint_lawsuit_against_Moderna_for_patent_infringement-lipid_nanoparticles_hocr.html

2.4M

2022-05-09_the_clinical_progress_of_mRNA_vaccines_and_immunotherapies-s41587-022-01294-2_hocr.html

244.6K

2022-05-19_why_lipid_nanoparticles_are_the_future_of_gene_therapy_and_what_needs_to_happen_next_hocr.html

5.3M

2022-05-24_lipid_nanoparticle_compositions_and_methods_for_mRNA_delivery-patent_no_11-338-044-B2_hocr.html

2.4M

2022-07-03_the_role_of_lipid_components_in_lipid_nanoparticles_for_vaccines_and_gene_therapy_hocr.html

978.1K

2022-07_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.)_hocr.html

1.7M

2022-09-02_pre-exposure_to_mRNA-LNP_inhibits_adaptive_immune_responses_and_alters_innate_immune_fitness_in_an_inheritable_fashion-journal.ppat.1010830_hocr.html

1.3M

2022-09-09_psychotropic_drugs_interaction_with_the_lipid_nanoparticle_of_COVID-19_mRNA_therapeutics-fphar-13-995481_hocr.html

1.6M

2022-10_delivery_of_RNAs_to_specific_organs_by_lipid_nanoparticles_for_gene_therapy-pharmaceutics-14-02129_hocr.html

1.8M

2022-12-22_lipid_nanoparticle_composition_drives_mRNA_delivery_to_the_placenta-521490v1.full_hocr.html

959.3K

2022_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.) - Beste Gruesse_hocr.html

855.4K

2023-01-02_relative_lethality_of_covid-19_vaccines-who_is_measuring_the_casualties-Geoff Pain PhD_hocr.html

2.0M

2023-01-26_chemical-physical_criticality_and_toxicological_potential_of_lipid_nanomaterials_contained_in_a_COVID-19_mRNA_vaccine_hocr.html

210.9K

2023-02-24_biontech-impfstoff_kein polydispersitätstest_vom paul-ehrlich-Berliner Zeitung_hocr.html

130.9K

2023-03-02_lipid_nanoparticles_highly_effective_in_gene_therapy-Hokkaido University_hocr.html

1.8M

2023-03-08_ionizable_lipid_nanoparticles_for_in_vivo_mRNA_delivery_to_the_placenta_during_pregnancy-nihms-1878359_hocr.html

3.5M

2023-04-01_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_hocr.html

1,001.3K

2023-10-23_apparent_cytotoxicity_and_intrinsic_cytotoxitiy_of_lipid_nanomaterials_contained_in_a_COVID-19-mRNA_vaccine-07102023_R1-4_hocr.html

42.5M

Gene_Therapy-tools_and_potential_applications-Francisco Martin Molina_hocr.html

209.2K

LP0008-LNO-0315-material_safety_data_sheet-msds-LP008.-for_research_use_only_hocr.html

20.1K

LP002-ALC-0315-lipid_nanoparticle-for_research_use_only_hocr.html

208.7K

LP002-ALC-0315-material_safety_data_sheet_hocr.html

21.6K

LP003-ALC-0159-PEG-lipid_conjugate-for_research_use_only_hocr.html

208.9K

LP003-ALC-0159_material_safety_data_sheet-msds-LP003_hocr.html

31.3K

LP008-LNP-0315_lipid_nanoparticle-for_research_use_only_hocr.html

1.0M

Pfizer-report_Japanese-government_hocr.html

1.7M

Toxicological Concerns Related to Nanoscale Drug Delivery Systems_hocr.html

148.0K

Transfektion_hocr.html

367.4K

biodistribution_of_Pfizer_Lipid_Nano_Particles-Byram Bridle_hocr.html

119.0K

transfection-PEG_liposome_transfection-invivotransfection.com_hocr.html

117.4K

transfection-in_vivo-invivotransfection.com_hocr.html

129.3K

transfection-lipid-based_transfection-invivotransfection.com_hocr.html

83.7K

transfection-nanoparticle_transfection-invivotransfection.com_hocr.html

219.0K

what_is_cationic_lipid_transfection-thermo fisher scientific_hocr.html

1 file

ITEM TILE

132 files

OCR PAGE INDEX

BACK

39.0B

0000-lipid-nanoparticles_hocr_pageindex.json.gz

100.0B

1989-08_cationic_liposome-mediated_RNA_transfection-6077.full_hocr_pageindex.json.gz

176.0B

2005-02_the role_of_plasmid_constructs_containing_the_SV40_DNA_nuclear-targeting_sequence_in_cationic_lipid-mediated_DNA_delivery (Circular and Molecular Biology Letters - Vol10_p203_hocr_pageindex.json.gz

153.0B

2006-04-14_toxicity_of_cationic_lipids_and_cationic_polymers_in_gene_delivery-journal of controlled release-markiert_hocr_pageindex.json.gz

153.0B

2007-08_Cationic_lipids_used_in_non-viral_gene_delivery_systems-article1381164572_Uddin_hocr_pageindex.json.gz

365.0B

2008_Nanotechnologie_in_Arzneimitteln_und_Medizinprodukten-Bruno Gander-Institute of Pharmaceutical Sciences-ETH Zürich_hocr_pageindex.json.gz

142.0B

2010-06-11_the_systemic_toxicity_of_positively_charged _lipid_nanoparticles_and_the_role_of_Toll-like_receptor_4_in_immune_activation_hocr_pageindex.json.gz

187.0B

2011-02_nanoparticulate_drug_delivery_in_pregnancy_placental_passage_and_fetal_exposure_hocr_pageindex.json.gz

152.0B

2011_transport_of_nanoparticles_through_the_placental_barrier_hocr_pageindex.json.gz

129.0B

2012-02-21_accumulation_of_nanocarriers_in_the_ovary-a_neglected_toxicity_risk_hocr_pageindex.json.gz

288.0B

2012-10-18_composite_magnetic_nanoparticle_drug_delivery_system-US-Patent_20120265001A1_hocr_pageindex.json.gz

639.0B

2014-01_emerging_research_and_clinical_developement_trends_of_liposome_and_lipid_nanoparticle_drug_delivery_systems-nihms-577214_hocr_pageindex.json.gz

298.0B

2014-09-19_mRNA-based_therapeutics-developing_a_new_class_of_drugs-Sahin2014mRNAreview_hocr_pageindex.json.gz

5.0K

2014_advances_in_genetics-non_viral_vectors_for_gene_therapy-lipid- and_polymer-based_gene_transfer-volume 88-Huang, Leaf_ Liu, Dexi_ Wagner, Ernst - Academic Press,Elsevier_hocr_pageindex.json.gz

1.5K

2014_nanoparticles_and_the_immune_system-safety_and_effects-Diana Boraschi and Albert Duschl (Eds.)-Academic Press_hocr_pageindex.json.gz

779.0B

2015-03_engeneering_of_lipid_nanoparticles_for_advanced_drug_delivery_hocr_pageindex.json.gz

3.5K

2015_non-viral_vectors_for_gene_therapy-physical_methods_and_medical_translation, Volume 89-Academic Press - Advances in Genetics - Leaf Huang, Dexi Liu, Ernst Wagner_hocr_pageindex.json.gz

730.0B

2016-08-11_lipid_nanoparticles_and_uses_thereof-patent_WO2016123864A1_hocr_pageindex.json.gz

273.0B

2016-08-31_lipid_nanoparticles_for_gene_delivery-nihms812782_hocr_pageindex.json.gz

218.0B

2016-09-13_Ego,_ambition,_and_turmoil-Inside_one_of_biotech's_most_secretive_startups-Statnews_hocr_pageindex.json.gz

307.0B

2016-10-31_toxicity_of_graphene-family_nanoparticles-a_general_review_of_the_origins_and_mechanisms_hocr_pageindex.json.gz

301.0B

2016_nanoparticle_transport_across_the_placental_barrier-pushing_the_field_forward_hocr_pageindex.json.gz

2.8K

2017-05_development_and_characterization_of_microencapsulated_nanoparticle_systems_for_oral_vaccination_by_Protein-Antigens-Dissertation_hocr_pageindex.json.gz

137.0B

2017-07_lipid_nanoparticle_systems_for_enabling_gene_therapies_hocr_pageindex.json.gz

121.0B

2018-04-05_correlation_of_the_cytotoxic_effects_of_cationic_lipids_with_their_headgroups_hocr_pageindex.json.gz

259.0B

2018-04-11_potential_adverse_effects_of_nanoparticles_in_the_reproductive_system-ijn-170723_hocr_pageindex.json.gz

165.0B

2018-06-06_a_novel_amino_lipid_series_for_mRNA_delivery-improved_endosomal_escape_and_sustained_pharmacology_and_safety_in_non-human_primates_hocr_pageindex.json.gz

95.0B

2018-1-16_liposomes_and_lipid_nanoparticles_as_delivery_vehicles_for_personalized_medicine_hocr_pageindex.json.gz

63.0B

2019-01-08_gene_therapy_in_the_era_of_nanotechnology-a_review_of_current_data-JCPCR-10-00380_hocr_pageindex.json.gz

486.0B

2019-046-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_hocr_pageindex.json.gz

187.0B

2019-05-07_lipid_nanoparticles_for_deliveery_of_therapeutic_RNA_oligonucleotides-moss2019_hocr_pageindex.json.gz

487.0B

2019-06-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_hocr_pageindex.json.gz

153.0B

2019-08-09_Lipid_Nanoparticle_Technology_for_Clinical_Translation_of_siRNA_Therapeutics-Kulkarni et al-markiert_hocr_pageindex.json.gz

76.0B

2019-08-27_biologisches_Gefahrenpotenzial_von_Nanopartikeln_untersucht_hocr_pageindex.json.gz

60.0B

2020-01-05_Lipid_Nanoparticles_in_COVID-19_vaccines-letter_to_Peter Marks-Aaron Siri_hocr_pageindex.json.gz

519.0B

2020-02-20_nanomedicines_to_deliver_mRNA-state_of_the_art_and_future_perspectives-nanomaterials-10-00364-v2_hocr_pageindex.json.gz

152.0B

2020-03-16_lipid_nanoparticle_technology_for_clinical_translation_of_siRNA_therapeutics-ar9b00368 1..10_hocr_pageindex.json.gz

187.0B

2020-03-16_nanoparticles_versus_dendritic_cells_as_vehicles_to_deliver_mRNA_encoding_multipe_epitopes_for_immunotherapy-Gene_&_Cell_Therapy_hocr_pageindex.json.gz

189.0B

2020-04-22_self-amplifying_RNA_SARS-CoV-2_lipid_nanoparticle_vaccine_induces_equivalent_preclinical_antibody_titers_and_viral_neutralization_to_recovered_COVID-19_patients-055608v1.full_hocr_pageindex.json.gz

306.0B

2020-06-22_nanotechnology_for_COVID-19-therapeutics_and_vaccine_research-acsnano.0c04006_hocr_pageindex.json.gz

25.9K

265.0B

2020-07-02_lipid_nanoparticle_technology_for_therapeutic_gene_regulation_in_the_liver-1-s2.0-S0169409X20300727-main_hocr_pageindex.json.gz

208.0B

2020-07-03_a_brief_review_on_solid_lipid_nanoparticles-part_and_parcel_of_contemporary_drug_delivery_system-d0ra03491f_hocr_pageindex.json.gz

63.0B

2020-07-16_nano_drugs-let_the_blood-brain_barrier_no_longer_be_a_barrier-biopharma PEG_hocr_pageindex.json.gz

75.0B

2020-08-04_liposomes_vs. _lipid_nanoparticles-which_is_best_for_drug_delivery-biopharma PEG_hocr_pageindex.json.gz

232.0B

2020-10-23_advances_in_lipid_nanoparticles_for_mRNA-based_cancer_immunotherapy-fchem-08-589959_hocr_pageindex.json.gz

311.0B

2020-10-30_solid_lipid_nanoparticles_for_drug_delivery-pharmacological_and_biopharmaceutical_aspects-fmolb-07-587997_hocr_pageindex.json.gz

893.0B

149.0B

2020-11-16_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v1_02_nr-1_hocr_pageindex.json.gz

1.3K

2020_exocomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_hocr_pageindex.json.gz

1.3K

2020_exosomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_hocr_pageindex.json.gz

221.0B

2021-01-13_ionizable_lipid_nanoparticles_for_in_utero_mRNA_delivery-sciadv.aba1028_hocr_pageindex.json.gz

820.0B

2021-01-20_saudi_medicinal_assessment_report-Pfizer-BioNTech_COVID-19_Vaccine_hocr_pageindex.json.gz

332.0B

2021-02-02_lipid_nanoparticles_as_delivery_systems_for_RNA-based_vaccines-pharmaceutics-13-00206-v3_hocr_pageindex.json.gz

76.0B

2021-02-09_Lipidnanopartikel_in_COVID-19-Impfung-PEG_und _ihr _allergenes_Potenzial_in_Impfstoffen_hocr_pageindex.json.gz

93.0B

2021-02-11_Nanopartikel_in_mRNA-Impfstoffen-PTAheute_hocr_pageindex.json.gz

41.0B

2021-02-11_SM-102_amino_lipid_product_information_hocr_pageindex.json.gz

1.0K

2021-02-12_Comirnaty-report_on_the_deliberation_results-pharmaceutical_evaluatiob_division_hocr_pageindex.json.gz

326.0B

2021-02-13_nanomedicine_for_COVID-19_the_role_of_nanotechnology_in_the_treatment_and_diagnosis_of_COVID-19_hocr_pageindex.json.gz

62.0B

2021-03-04_editorial-lipid_nanoparticles_as_a_novel_strategy_to_deliver_bioactive_molecules_hocr_pageindex.json.gz

118.0B

2021-03-06_without_these_lipid_shells,_there_would_be_no_mRNA_vaccines_for_COVID-19_hocr_pageindex.json.gz

118.0B

2021-03_Vaccine_development_for_coronavirus_SARS-CoV-2_disease-lipid_nanoparticles-IJRSI_hocr_pageindex.json.gz

348.0B

2021-04-03_the_mRNA-LNP_platform’s_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory_hocr_pageindex.json.gz

366.0B

2021-04-08_lipd-based_nanoparticles_in_the_clinic_and_clinical_trials_from_cancer_nanomedicine_to_COVID-19_vaccines-09-00359_hocr_pageindex.json.gz

230.0B

2021-04-11_Nanotechnologie_der_Covid-19-Vakzinen-Pharmazeutische Zeitung_hocr_pageindex.json.gz

136.0B

2021-04-24_future_considerations_for_the_mRNA-lipid_nanoparticle_vaccine_platform_hocr_pageindex.json.gz

151.0B

2021-05-18_impact_of_lipid_nanparticle_size_on_mRNA_vaccine_immunogenicity-1-s2.0-S0168365921002376-main_hocr_pageindex.json.gz

145.0B

2021-05-28_antiphospholipid_antibodies_and_risk_of_post-COVID-19_vaccination_thrombophilia-The_straw_that_breaks_the_camel’s_back_hocr_pageindex.json.gz

76.0B

2021-05-28_wie_gefährlich_sind_Lipidnanopartikel_in_mRNA-Impfstoffen-schiftl_Anfrage_bayerischer_Landtag-18_0016664_hocr_pageindex.json.gz

96.0B

2021-06-02_gene_therapy_avenues_and_COVID-19-vaccines-s41435-021-00136-6_hocr_pageindex.json.gz

902.0B

2021-06-04_COVID-19_mRNA_Vaccine_BNT162b2_UKPAR_PFIZER_BIONTECH_ext_of_indication_hocr_pageindex.json.gz

77.0B

2021-06-11_overview_of_mRNA-lipid_nanoparticle_covid-19_vaccines-biopharma-PEG_hocr_pageindex.json.gz

59.0B

2021-06-14_Protein_Nanopartikel_Vakzine-BG-Kliniken_hocr_pageindex.json.gz

420.0B

2021-06-28_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_hocr_pageindex.json.gz

41.0B

2021-07-23_ALC-0159-lipid-N-2010_TDS_rev1_hocr_pageindex.json.gz

40.0B

2021-07-23_ALC-0315-lipid-N-1020_TDS_rev1a_hocr_pageindex.json.gz

41.0B

2021-07-30_Lipid_Nanopartikel_ALC-0159_product_information-item_number_34336_hocr_pageindex.json.gz

205.0B

2021-08-11_ionization_and_structural_properties_of_mRNA_lipid_nanoparticles_influence_expression_in_intramuscular_and_intravascular_administration-s42003-021-02441-2_hocr_pageindex.json.gz

117.0B

2021-08-24_ALC-0159_Lipid-Nanopartikel-saety_data_sheet-34336m_hocr_pageindex.json.gz

642.0B

2021-08_novel_lipid_nanoparticle_provides_potent_SARS-CoV2_mRNA _vaccine_at_low_dose_with_low_local_reactogenicity,_high_thermostability_and_limited_systemic_biosdistribution_hocr_pageindex.json.gz

156.0B

2021-09-15_SM-102_amino_lipid_safety_data_sheet_hocr_pageindex.json.gz

77.0B

2021-10-09_lipid_nanoparticles_for_drug_and_vaccine_delivery-Biopharma PEG_hocr_pageindex.json.gz

361.0B

2021-10-26_lipid_nanoparticle_drug_delivery_systems-recent_advances_in_the_treatment_of_skin_disorders-pharmaceuticals-14-01083-v2_hocr_pageindex.json.gz

370.0B

2021-11-08_summary_basis_for_regulatory_action-Comirnaty_hocr_pageindex.json.gz

168.0B

2021-12-07_Pfizer_safety_data_sheet-PF00092-lipid_nanoparticles_MTR_PFEM_EN_hocr_pageindex.json.gz

158.0B

2021-12-14_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v2 (104a-pf00161-mtr-pfem-en-002)_hocr_pageindex.json.gz

89.0B

2021-12-17_potential_implications_of_lipid_nanoparticles_in_the_pathogenesis_of_myocarditis_associated_with_the_use_of_mRNA_vaccines_against_SARS-CoV-2-1-s2.0-S2589936821000839-main_hocr_pageindex.json.gz

214.0B

2021-12-17_the_mRNA-LNP_platform's_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory-CellPress-article_hocr_pageindex.json.gz

496.0B

2021-12-27_Rechtsgutachten_zur_Strafbarkeit_der_Impfung_nach_95 AMG-Beate Bahner_hocr_pageindex.json.gz

41.0B

2021-12_lasting_impact_of_lipid_nanoparticles-s41578-021-00398-6_hocr_pageindex.json.gz

230.0B

2021-12_lipid_nanoparticles_for_mRNA_delivery-review-s41578-021-00358-0_hocr_pageindex.json.gz

63.0B

2021-12_replication_of_SARS-CoV-2_in_adipose_tissue_determines_organ_and_systemic_lipid_metabolism_in_hamsters_and_humans-1-s2.0-S1550413121006215-main_hocr_pageindex.json.gz

61.0B

2021-BioNTech_factsheet_BNT162b2_manufacturing_process_&_ingredients_hocr_pageindex.json.gz

284.0B

2022-01-08_Anti-PEG_antibodies_boosted_in_humans_by_SARS-CoV-2_lipid_nanoparticle_mRNA_vaccine-22268953v1.full_hocr_pageindex.json.gz

215.0B

2022-01-11_non-viral_delivery_of_RNA_gene_therapy_to_the_central_nervous_system-Hauck-JournalArticle-2022_hocr_pageindex.json.gz

114.0B

2022-01-16_Lipid_Nanoparticles_kill_80_percent_of_mice_in_PubMed_Study-thedesertreview_hocr_pageindex.json.gz

153.0B

2022-01-26_biodistribution_and_non-linear_gene_expression_of_mRNA_LNPs_affected_by_delivery_route_and_particle_size_hocr_pageindex.json.gz

117.0B

2022-02-16_BIONTECH_Antwort_an_Pathologie-Konferenz_hocr_pageindex.json.gz

600.0B

2022-02-28_complaint_lawsuit_against_Moderna_for_patent_infringement-lipid_nanoparticles_hocr_pageindex.json.gz

211.0B

2022-05-09_the_clinical_progress_of_mRNA_vaccines_and_immunotherapies-s41587-022-01294-2_hocr_pageindex.json.gz

84.0B

2022-05-19_why_lipid_nanoparticles_are_the_future_of_gene_therapy_and_what_needs_to_happen_next_hocr_pageindex.json.gz

763.0B

2022-05-24_lipid_nanoparticle_compositions_and_methods_for_mRNA_delivery-patent_no_11-338-044-B2_hocr_pageindex.json.gz

228.0B

2022-07-03_the_role_of_lipid_components_in_lipid_nanoparticles_for_vaccines_and_gene_therapy_hocr_pageindex.json.gz

139.0B

2022-07_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.)_hocr_pageindex.json.gz

294.0B

2022-09-02_pre-exposure_to_mRNA-LNP_inhibits_adaptive_immune_responses_and_alters_innate_immune_fitness_in_an_inheritable_fashion-journal.ppat.1010830_hocr_pageindex.json.gz

153.0B

2022-09-09_psychotropic_drugs_interaction_with_the_lipid_nanoparticle_of_COVID-19_mRNA_therapeutics-fphar-13-995481_hocr_pageindex.json.gz

267.0B

2022-10_delivery_of_RNAs_to_specific_organs_by_lipid_nanoparticles_for_gene_therapy-pharmaceutics-14-02129_hocr_pageindex.json.gz

509.0B

2022-12-22_lipid_nanoparticle_composition_drives_mRNA_delivery_to_the_placenta-521490v1.full_hocr_pageindex.json.gz

302.0B

2022_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.) - Beste Gruesse_hocr_pageindex.json.gz

181.0B

2023-01-02_relative_lethality_of_covid-19_vaccines-who_is_measuring_the_casualties-Geoff Pain PhD_hocr_pageindex.json.gz

381.0B

2023-01-26_chemical-physical_criticality_and_toxicological_potential_of_lipid_nanomaterials_contained_in_a_COVID-19_mRNA_vaccine_hocr_pageindex.json.gz

84.0B

2023-02-24_biontech-impfstoff_kein polydispersitätstest_vom paul-ehrlich-Berliner Zeitung_hocr_pageindex.json.gz

87.0B

2023-03-02_lipid_nanoparticles_highly_effective_in_gene_therapy-Hokkaido University_hocr_pageindex.json.gz

387.0B

2023-03-08_ionizable_lipid_nanoparticles_for_in_vivo_mRNA_delivery_to_the_placenta_during_pregnancy-nihms-1878359_hocr_pageindex.json.gz

422.0B

2023-04-01_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_hocr_pageindex.json.gz

211.0B

2023-10-23_apparent_cytotoxicity_and_intrinsic_cytotoxitiy_of_lipid_nanomaterials_contained_in_a_COVID-19-mRNA_vaccine-07102023_R1-4_hocr_pageindex.json.gz

9.0K

Gene_Therapy-tools_and_potential_applications-Francisco Martin Molina_hocr_pageindex.json.gz

105.0B

LP0008-LNO-0315-material_safety_data_sheet-msds-LP008.-for_research_use_only_hocr_pageindex.json.gz

42.0B

LP002-ALC-0315-lipid_nanoparticle-for_research_use_only_hocr_pageindex.json.gz

106.0B

LP002-ALC-0315-material_safety_data_sheet_hocr_pageindex.json.gz

40.0B

LP003-ALC-0159-PEG-lipid_conjugate-for_research_use_only_hocr_pageindex.json.gz

105.0B

LP003-ALC-0159_material_safety_data_sheet-msds-LP003_hocr_pageindex.json.gz

43.0B

LP008-LNP-0315_lipid_nanoparticle-for_research_use_only_hocr_pageindex.json.gz

283.0B

Pfizer-report_Japanese-government_hocr_pageindex.json.gz

343.0B

Toxicological Concerns Related to Nanoscale Drug Delivery Systems_hocr_pageindex.json.gz

59.0B

Transfektion_hocr_pageindex.json.gz

115.0B

biodistribution_of_Pfizer_Lipid_Nano_Particles-Byram Bridle_hocr_pageindex.json.gz

83.0B

transfection-PEG_liposome_transfection-invivotransfection.com_hocr_pageindex.json.gz

76.0B

transfection-in_vivo-invivotransfection.com_hocr_pageindex.json.gz

84.0B

transfection-lipid-based_transfection-invivotransfection.com_hocr_pageindex.json.gz

73.0B

transfection-nanoparticle_transfection-invivotransfection.com_hocr_pageindex.json.gz

83.0B

what_is_cationic_lipid_transfection-thermo fisher scientific_hocr_pageindex.json.gz

132 files

OCR SEARCH TEXT

BACK

138.0B

0000-lipid-nanoparticles_hocr_searchtext.txt.gz

9.7K

1989-08_cationic_liposome-mediated_RNA_transfection-6077.full_hocr_searchtext.txt.gz

10.8K

19.5K

2006-04-14_toxicity_of_cationic_lipids_and_cationic_polymers_in_gene_delivery-journal of controlled release-markiert_hocr_searchtext.txt.gz

18.2K

2007-08_Cationic_lipids_used_in_non-viral_gene_delivery_systems-article1381164572_Uddin_hocr_searchtext.txt.gz

12.2K

2008_Nanotechnologie_in_Arzneimitteln_und_Medizinprodukten-Bruno Gander-Institute of Pharmaceutical Sciences-ETH Zürich_hocr_searchtext.txt.gz

17.3K

2010-06-11_the_systemic_toxicity_of_positively_charged _lipid_nanoparticles_and_the_role_of_Toll-like_receptor_4_in_immune_activation_hocr_searchtext.txt.gz

30.7K

2011-02_nanoparticulate_drug_delivery_in_pregnancy_placental_passage_and_fetal_exposure_hocr_searchtext.txt.gz

18.8K

2011_transport_of_nanoparticles_through_the_placental_barrier_hocr_searchtext.txt.gz

16.8K

2012-02-21_accumulation_of_nanocarriers_in_the_ovary-a_neglected_toxicity_risk_hocr_searchtext.txt.gz

21.7K

2012-10-18_composite_magnetic_nanoparticle_drug_delivery_system-US-Patent_20120265001A1_hocr_searchtext.txt.gz

58.6K

2014-01_emerging_research_and_clinical_developement_trends_of_liposome_and_lipid_nanoparticle_drug_delivery_systems-nihms-577214_hocr_searchtext.txt.gz

47.6K

2014-09-19_mRNA-based_therapeutics-developing_a_new_class_of_drugs-Sahin2014mRNAreview_hocr_searchtext.txt.gz

381.2K

2014_advances_in_genetics-non_viral_vectors_for_gene_therapy-lipid- and_polymer-based_gene_transfer-volume 88-Huang, Leaf_ Liu, Dexi_ Wagner, Ernst - Academic Press,Elsevier_hocr_searchtext.txt.gz

104.0K

2014_nanoparticles_and_the_immune_system-safety_and_effects-Diana Boraschi and Albert Duschl (Eds.)-Academic Press_hocr_searchtext.txt.gz

33.2K

2015-03_engeneering_of_lipid_nanoparticles_for_advanced_drug_delivery_hocr_searchtext.txt.gz

250.8K

2015_non-viral_vectors_for_gene_therapy-physical_methods_and_medical_translation, Volume 89-Academic Press - Advances in Genetics - Leaf Huang, Dexi Liu, Ernst Wagner_hocr_searchtext.txt.gz

40.4K

2016-08-11_lipid_nanoparticles_and_uses_thereof-patent_WO2016123864A1_hocr_searchtext.txt.gz

24.2K

2016-08-31_lipid_nanoparticles_for_gene_delivery-nihms812782_hocr_searchtext.txt.gz

12.1K

2016-09-13_Ego,_ambition,_and_turmoil-Inside_one_of_biotech's_most_secretive_startups-Statnews_hocr_searchtext.txt.gz

44.0K

2016-10-31_toxicity_of_graphene-family_nanoparticles-a_general_review_of_the_origins_and_mechanisms_hocr_searchtext.txt.gz

24.8K

2016_nanoparticle_transport_across_the_placental_barrier-pushing_the_field_forward_hocr_searchtext.txt.gz

133.5K

2017-05_development_and_characterization_of_microencapsulated_nanoparticle_systems_for_oral_vaccination_by_Protein-Antigens-Dissertation_hocr_searchtext.txt.gz

16.1K

2017-07_lipid_nanoparticle_systems_for_enabling_gene_therapies_hocr_searchtext.txt.gz

10.4K

2018-04-05_correlation_of_the_cytotoxic_effects_of_cationic_lipids_with_their_headgroups_hocr_searchtext.txt.gz

33.8K

2018-04-11_potential_adverse_effects_of_nanoparticles_in_the_reproductive_system-ijn-170723_hocr_searchtext.txt.gz

20.7K

2018-06-06_a_novel_amino_lipid_series_for_mRNA_delivery-improved_endosomal_escape_and_sustained_pharmacology_and_safety_in_non-human_primates_hocr_searchtext.txt.gz

6.8K

2018-1-16_liposomes_and_lipid_nanoparticles_as_delivery_vehicles_for_personalized_medicine_hocr_searchtext.txt.gz

4.0K

2019-01-08_gene_therapy_in_the_era_of_nanotechnology-a_review_of_current_data-JCPCR-10-00380_hocr_searchtext.txt.gz

30.4K

2019-046-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_hocr_searchtext.txt.gz

32.1K

2019-05-07_lipid_nanoparticles_for_deliveery_of_therapeutic_RNA_oligonucleotides-moss2019_hocr_searchtext.txt.gz

30.4K

2019-06-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_hocr_searchtext.txt.gz

21.1K

2019-08-09_Lipid_Nanoparticle_Technology_for_Clinical_Translation_of_siRNA_Therapeutics-Kulkarni et al-markiert_hocr_searchtext.txt.gz

2.8K

2019-08-27_biologisches_Gefahrenpotenzial_von_Nanopartikeln_untersucht_hocr_searchtext.txt.gz

1.4K

2020-01-05_Lipid_Nanoparticles_in_COVID-19_vaccines-letter_to_Peter Marks-Aaron Siri_hocr_searchtext.txt.gz

60.1K

2020-02-20_nanomedicines_to_deliver_mRNA-state_of_the_art_and_future_perspectives-nanomaterials-10-00364-v2_hocr_searchtext.txt.gz

21.1K

2020-03-16_lipid_nanoparticle_technology_for_clinical_translation_of_siRNA_therapeutics-ar9b00368 1..10_hocr_searchtext.txt.gz

24.3K

2020-03-16_nanoparticles_versus_dendritic_cells_as_vehicles_to_deliver_mRNA_encoding_multipe_epitopes_for_immunotherapy-Gene_&_Cell_Therapy_hocr_searchtext.txt.gz

10.0K

52.7K

2020-06-22_nanotechnology_for_COVID-19-therapeutics_and_vaccine_research-acsnano.0c04006_hocr_searchtext.txt.gz

417.7K

60.6K

2020-07-02_lipid_nanoparticle_technology_for_therapeutic_gene_regulation_in_the_liver-1-s2.0-S0169409X20300727-main_hocr_searchtext.txt.gz

22.8K

2020-07-03_a_brief_review_on_solid_lipid_nanoparticles-part_and_parcel_of_contemporary_drug_delivery_system-d0ra03491f_hocr_searchtext.txt.gz

4.5K

2020-07-16_nano_drugs-let_the_blood-brain_barrier_no_longer_be_a_barrier-biopharma PEG_hocr_searchtext.txt.gz

4.3K

2020-08-04_liposomes_vs. _lipid_nanoparticles-which_is_best_for_drug_delivery-biopharma PEG_hocr_searchtext.txt.gz

31.1K

2020-10-23_advances_in_lipid_nanoparticles_for_mRNA-based_cancer_immunotherapy-fchem-08-589959_hocr_searchtext.txt.gz

52.4K

2020-10-30_solid_lipid_nanoparticles_for_drug_delivery-pharmacological_and_biopharmaceutical_aspects-fmolb-07-587997_hocr_searchtext.txt.gz

28.7K

6.9K

2020-11-16_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v1_02_nr-1_hocr_searchtext.txt.gz

90.7K

2020_exocomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_hocr_searchtext.txt.gz

90.5K

2020_exosomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_hocr_searchtext.txt.gz

34.1K

2021-01-13_ionizable_lipid_nanoparticles_for_in_utero_mRNA_delivery-sciadv.aba1028_hocr_searchtext.txt.gz

34.5K

2021-01-20_saudi_medicinal_assessment_report-Pfizer-BioNTech_COVID-19_Vaccine_hocr_searchtext.txt.gz

38.8K

2021-02-02_lipid_nanoparticles_as_delivery_systems_for_RNA-based_vaccines-pharmaceutics-13-00206-v3_hocr_searchtext.txt.gz

2.4K

2021-02-09_Lipidnanopartikel_in_COVID-19-Impfung-PEG_und _ihr _allergenes_Potenzial_in_Impfstoffen_hocr_searchtext.txt.gz

2.9K

2021-02-11_Nanopartikel_in_mRNA-Impfstoffen-PTAheute_hocr_searchtext.txt.gz

1.2K

2021-02-11_SM-102_amino_lipid_product_information_hocr_searchtext.txt.gz

64.3K

2021-02-12_Comirnaty-report_on_the_deliberation_results-pharmaceutical_evaluatiob_division_hocr_searchtext.txt.gz

52.9K

2021-02-13_nanomedicine_for_COVID-19_the_role_of_nanotechnology_in_the_treatment_and_diagnosis_of_COVID-19_hocr_searchtext.txt.gz

3.8K

2021-03-04_editorial-lipid_nanoparticles_as_a_novel_strategy_to_deliver_bioactive_molecules_hocr_searchtext.txt.gz

7.9K

2021-03-06_without_these_lipid_shells,_there_would_be_no_mRNA_vaccines_for_COVID-19_hocr_searchtext.txt.gz

14.5K

2021-03_Vaccine_development_for_coronavirus_SARS-CoV-2_disease-lipid_nanoparticles-IJRSI_hocr_searchtext.txt.gz

17.2K

2021-04-03_the_mRNA-LNP_platform’s_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory_hocr_searchtext.txt.gz

43.2K

2021-04-08_lipd-based_nanoparticles_in_the_clinic_and_clinical_trials_from_cancer_nanomedicine_to_COVID-19_vaccines-09-00359_hocr_searchtext.txt.gz

11.7K

2021-04-11_Nanotechnologie_der_Covid-19-Vakzinen-Pharmazeutische Zeitung_hocr_searchtext.txt.gz

12.9K

2021-04-24_future_considerations_for_the_mRNA-lipid_nanoparticle_vaccine_platform_hocr_searchtext.txt.gz

25.9K

2021-05-18_impact_of_lipid_nanparticle_size_on_mRNA_vaccine_immunogenicity-1-s2.0-S0168365921002376-main_hocr_searchtext.txt.gz

22.6K

2021-05-28_antiphospholipid_antibodies_and_risk_of_post-COVID-19_vaccination_thrombophilia-The_straw_that_breaks_the_camel’s_back_hocr_searchtext.txt.gz

3.9K

2021-05-28_wie_gefährlich_sind_Lipidnanopartikel_in_mRNA-Impfstoffen-schiftl_Anfrage_bayerischer_Landtag-18_0016664_hocr_searchtext.txt.gz

9.7K

2021-06-02_gene_therapy_avenues_and_COVID-19-vaccines-s41435-021-00136-6_hocr_searchtext.txt.gz

56.9K

2021-06-04_COVID-19_mRNA_Vaccine_BNT162b2_UKPAR_PFIZER_BIONTECH_ext_of_indication_hocr_searchtext.txt.gz

4.6K

2021-06-11_overview_of_mRNA-lipid_nanoparticle_covid-19_vaccines-biopharma-PEG_hocr_searchtext.txt.gz

2.3K

2021-06-14_Protein_Nanopartikel_Vakzine-BG-Kliniken_hocr_searchtext.txt.gz

61.3K

2021-06-28_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_hocr_searchtext.txt.gz

1.4K

2021-07-23_ALC-0159-lipid-N-2010_TDS_rev1_hocr_searchtext.txt.gz

1.5K

2021-07-23_ALC-0315-lipid-N-1020_TDS_rev1a_hocr_searchtext.txt.gz

1.4K

2021-07-30_Lipid_Nanopartikel_ALC-0159_product_information-item_number_34336_hocr_searchtext.txt.gz

29.5K

2021-08-11_ionization_and_structural_properties_of_mRNA_lipid_nanoparticles_influence_expression_in_intramuscular_and_intravascular_administration-s42003-021-02441-2_hocr_searchtext.txt.gz

4.5K

2021-08-24_ALC-0159_Lipid-Nanopartikel-saety_data_sheet-34336m_hocr_searchtext.txt.gz

33.6K

2021-08_novel_lipid_nanoparticle_provides_potent_SARS-CoV2_mRNA _vaccine_at_low_dose_with_low_local_reactogenicity,_high_thermostability_and_limited_systemic_biosdistribution_hocr_searchtext.txt.gz

7.3K

2021-09-15_SM-102_amino_lipid_safety_data_sheet_hocr_searchtext.txt.gz

5.4K

2021-10-09_lipid_nanoparticles_for_drug_and_vaccine_delivery-Biopharma PEG_hocr_searchtext.txt.gz

42.1K

2021-10-26_lipid_nanoparticle_drug_delivery_systems-recent_advances_in_the_treatment_of_skin_disorders-pharmaceuticals-14-01083-v2_hocr_searchtext.txt.gz

22.9K

2021-11-08_summary_basis_for_regulatory_action-Comirnaty_hocr_searchtext.txt.gz

7.9K

2021-12-07_Pfizer_safety_data_sheet-PF00092-lipid_nanoparticles_MTR_PFEM_EN_hocr_searchtext.txt.gz

7.7K

2021-12-14_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v2 (104a-pf00161-mtr-pfem-en-002)_hocr_searchtext.txt.gz

9.7K

23.5K

2021-12-17_the_mRNA-LNP_platform's_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory-CellPress-article_hocr_searchtext.txt.gz

23.5K

2021-12-27_Rechtsgutachten_zur_Strafbarkeit_der_Impfung_nach_95 AMG-Beate Bahner_hocr_searchtext.txt.gz

2.4K

2021-12_lasting_impact_of_lipid_nanoparticles-s41578-021-00398-6_hocr_searchtext.txt.gz

39.7K

2021-12_lipid_nanoparticles_for_mRNA_delivery-review-s41578-021-00358-0_hocr_searchtext.txt.gz

5.5K

2021-12_replication_of_SARS-CoV-2_in_adipose_tissue_determines_organ_and_systemic_lipid_metabolism_in_hamsters_and_humans-1-s2.0-S1550413121006215-main_hocr_searchtext.txt.gz

1.7K

2021-BioNTech_factsheet_BNT162b2_manufacturing_process_&_ingredients_hocr_searchtext.txt.gz

13.2K

2022-01-08_Anti-PEG_antibodies_boosted_in_humans_by_SARS-CoV-2_lipid_nanoparticle_mRNA_vaccine-22268953v1.full_hocr_searchtext.txt.gz

20.4K

2022-01-11_non-viral_delivery_of_RNA_gene_therapy_to_the_central_nervous_system-Hauck-JournalArticle-2022_hocr_searchtext.txt.gz

5.1K

2022-01-16_Lipid_Nanoparticles_kill_80_percent_of_mice_in_PubMed_Study-thedesertreview_hocr_searchtext.txt.gz

15.3K

2022-01-26_biodistribution_and_non-linear_gene_expression_of_mRNA_LNPs_affected_by_delivery_route_and_particle_size_hocr_searchtext.txt.gz

6.5K

2022-02-16_BIONTECH_Antwort_an_Pathologie-Konferenz_hocr_searchtext.txt.gz

20.2K

2022-02-28_complaint_lawsuit_against_Moderna_for_patent_infringement-lipid_nanoparticles_hocr_searchtext.txt.gz

42.9K

2022-05-09_the_clinical_progress_of_mRNA_vaccines_and_immunotherapies-s41587-022-01294-2_hocr_searchtext.txt.gz

4.2K

2022-05-19_why_lipid_nanoparticles_are_the_future_of_gene_therapy_and_what_needs_to_happen_next_hocr_searchtext.txt.gz

74.3K

2022-05-24_lipid_nanoparticle_compositions_and_methods_for_mRNA_delivery-patent_no_11-338-044-B2_hocr_searchtext.txt.gz

41.4K

2022-07-03_the_role_of_lipid_components_in_lipid_nanoparticles_for_vaccines_and_gene_therapy_hocr_searchtext.txt.gz

15.6K

2022-07_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.)_hocr_searchtext.txt.gz

27.3K

2022-09-02_pre-exposure_to_mRNA-LNP_inhibits_adaptive_immune_responses_and_alters_innate_immune_fitness_in_an_inheritable_fashion-journal.ppat.1010830_hocr_searchtext.txt.gz

23.9K

2022-09-09_psychotropic_drugs_interaction_with_the_lipid_nanoparticle_of_COVID-19_mRNA_therapeutics-fphar-13-995481_hocr_searchtext.txt.gz

25.9K

2022-10_delivery_of_RNAs_to_specific_organs_by_lipid_nanoparticles_for_gene_therapy-pharmaceutics-14-02129_hocr_searchtext.txt.gz

28.0K

2022-12-22_lipid_nanoparticle_composition_drives_mRNA_delivery_to_the_placenta-521490v1.full_hocr_searchtext.txt.gz

15.2K

2022_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.) - Beste Gruesse_hocr_searchtext.txt.gz

15.9K

2023-01-02_relative_lethality_of_covid-19_vaccines-who_is_measuring_the_casualties-Geoff Pain PhD_hocr_searchtext.txt.gz

33.0K

2023-01-26_chemical-physical_criticality_and_toxicological_potential_of_lipid_nanomaterials_contained_in_a_COVID-19_mRNA_vaccine_hocr_searchtext.txt.gz

4.4K

2023-02-24_biontech-impfstoff_kein polydispersitätstest_vom paul-ehrlich-Berliner Zeitung_hocr_searchtext.txt.gz

2.4K

2023-03-02_lipid_nanoparticles_highly_effective_in_gene_therapy-Hokkaido University_hocr_searchtext.txt.gz

26.4K

2023-03-08_ionizable_lipid_nanoparticles_for_in_vivo_mRNA_delivery_to_the_placenta_during_pregnancy-nihms-1878359_hocr_searchtext.txt.gz

61.3K

2023-04-01_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_hocr_searchtext.txt.gz

17.1K

2023-10-23_apparent_cytotoxicity_and_intrinsic_cytotoxitiy_of_lipid_nanomaterials_contained_in_a_COVID-19-mRNA_vaccine-07102023_R1-4_hocr_searchtext.txt.gz

696.8K

Gene_Therapy-tools_and_potential_applications-Francisco Martin Molina_hocr_searchtext.txt.gz

3.4K

LP0008-LNO-0315-material_safety_data_sheet-msds-LP008.-for_research_use_only_hocr_searchtext.txt.gz

451.0B

LP002-ALC-0315-lipid_nanoparticle-for_research_use_only_hocr_searchtext.txt.gz

3.4K

LP002-ALC-0315-material_safety_data_sheet_hocr_searchtext.txt.gz

542.0B

LP003-ALC-0159-PEG-lipid_conjugate-for_research_use_only_hocr_searchtext.txt.gz

3.4K

LP003-ALC-0159_material_safety_data_sheet-msds-LP003_hocr_searchtext.txt.gz

751.0B

LP008-LNP-0315_lipid_nanoparticle-for_research_use_only_hocr_searchtext.txt.gz

13.4K

Pfizer-report_Japanese-government_hocr_searchtext.txt.gz

32.2K

Toxicological Concerns Related to Nanoscale Drug Delivery Systems_hocr_searchtext.txt.gz

3.1K

Transfektion_hocr_searchtext.txt.gz

6.6K

biodistribution_of_Pfizer_Lipid_Nano_Particles-Byram Bridle_hocr_searchtext.txt.gz

2.4K

transfection-PEG_liposome_transfection-invivotransfection.com_hocr_searchtext.txt.gz

2.5K

transfection-in_vivo-invivotransfection.com_hocr_searchtext.txt.gz

2.6K

transfection-lipid-based_transfection-invivotransfection.com_hocr_searchtext.txt.gz

1.7K

transfection-nanoparticle_transfection-invivotransfection.com_hocr_searchtext.txt.gz

4.0K

what_is_cationic_lipid_transfection-thermo fisher scientific_hocr_searchtext.txt.gz

132 files

PAGE NUMBERS JSON

BACK

311.0B

0000-lipid-nanoparticles_page_numbers.json

982.0B

1989-08_cationic_liposome-mediated_RNA_transfection-6077.full_page_numbers.json

2.3K

1.8K

2006-04-14_toxicity_of_cationic_lipids_and_cationic_polymers_in_gene_delivery-journal of controlled release-markiert_page_numbers.json

1.8K

2007-08_Cationic_lipids_used_in_non-viral_gene_delivery_systems-article1381164572_Uddin_page_numbers.json

5.3K

2008_Nanotechnologie_in_Arzneimitteln_und_Medizinprodukten-Bruno Gander-Institute of Pharmaceutical Sciences-ETH Zürich_page_numbers.json

1.6K

2010-06-11_the_systemic_toxicity_of_positively_charged _lipid_nanoparticles_and_the_role_of_Toll-like_receptor_4_in_immune_activation_page_numbers.json

2.2K

2011-02_nanoparticulate_drug_delivery_in_pregnancy_placental_passage_and_fetal_exposure_page_numbers.json

1.8K

2011_transport_of_nanoparticles_through_the_placental_barrier_page_numbers.json

1.5K

2012-02-21_accumulation_of_nanocarriers_in_the_ovary-a_neglected_toxicity_risk_page_numbers.json

4.1K

2012-10-18_composite_magnetic_nanoparticle_drug_delivery_system-US-Patent_20120265001A1_page_numbers.json

8.5K

2014-01_emerging_research_and_clinical_developement_trends_of_liposome_and_lipid_nanoparticle_drug_delivery_systems-nihms-577214_page_numbers.json

3.9K

2014-09-19_mRNA-based_therapeutics-developing_a_new_class_of_drugs-Sahin2014mRNAreview_page_numbers.json

69.3K

2014_advances_in_genetics-non_viral_vectors_for_gene_therapy-lipid- and_polymer-based_gene_transfer-volume 88-Huang, Leaf_ Liu, Dexi_ Wagner, Ernst - Academic Press,Elsevier_page_numbers.json

20.6K

2014_nanoparticles_and_the_immune_system-safety_and_effects-Diana Boraschi and Albert Duschl (Eds.)-Academic Press_page_numbers.json

11.2K

2015-03_engeneering_of_lipid_nanoparticles_for_advanced_drug_delivery_page_numbers.json

48.7K

2015_non-viral_vectors_for_gene_therapy-physical_methods_and_medical_translation, Volume 89-Academic Press - Advances in Genetics - Leaf Huang, Dexi Liu, Ernst Wagner_page_numbers.json

10.2K

2016-08-11_lipid_nanoparticles_and_uses_thereof-patent_WO2016123864A1_page_numbers.json

3.5K

2016-08-31_lipid_nanoparticles_for_gene_delivery-nihms812782_page_numbers.json

2.9K

2016-09-13_Ego,_ambition,_and_turmoil-Inside_one_of_biotech's_most_secretive_startups-Statnews_page_numbers.json

4.0K

2016-10-31_toxicity_of_graphene-family_nanoparticles-a_general_review_of_the_origins_and_mechanisms_page_numbers.json

4.1K

2016_nanoparticle_transport_across_the_placental_barrier-pushing_the_field_forward_page_numbers.json

38.9K

2017-05_development_and_characterization_of_microencapsulated_nanoparticle_systems_for_oral_vaccination_by_Protein-Antigens-Dissertation_page_numbers.json

1.6K

2017-07_lipid_nanoparticle_systems_for_enabling_gene_therapies_page_numbers.json

1.3K

2018-04-05_correlation_of_the_cytotoxic_effects_of_cationic_lipids_with_their_headgroups_page_numbers.json

3.4K

2018-04-11_potential_adverse_effects_of_nanoparticles_in_the_reproductive_system-ijn-170723_page_numbers.json

1.9K

2018-06-06_a_novel_amino_lipid_series_for_mRNA_delivery-improved_endosomal_escape_and_sustained_pharmacology_and_safety_in_non-human_primates_page_numbers.json

983.0B

2018-1-16_liposomes_and_lipid_nanoparticles_as_delivery_vehicles_for_personalized_medicine_page_numbers.json

479.0B

2019-01-08_gene_therapy_in_the_era_of_nanotechnology-a_review_of_current_data-JCPCR-10-00380_page_numbers.json

6.8K

2019-046-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_page_numbers.json

2.3K

2019-05-07_lipid_nanoparticles_for_deliveery_of_therapeutic_RNA_oligonucleotides-moss2019_page_numbers.json

6.8K

2019-06-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_page_numbers.json

1.8K

2019-08-09_Lipid_Nanoparticle_Technology_for_Clinical_Translation_of_siRNA_Therapeutics-Kulkarni et al-markiert_page_numbers.json

633.0B

2019-08-27_biologisches_Gefahrenpotenzial_von_Nanopartikeln_untersucht_page_numbers.json

479.0B

2020-01-05_Lipid_Nanoparticles_in_COVID-19_vaccines-letter_to_Peter Marks-Aaron Siri_page_numbers.json

7.0K

2020-02-20_nanomedicines_to_deliver_mRNA-state_of_the_art_and_future_perspectives-nanomaterials-10-00364-v2_page_numbers.json

1.8K

2020-03-16_lipid_nanoparticle_technology_for_clinical_translation_of_siRNA_therapeutics-ar9b00368 1..10_page_numbers.json

2.2K

2020-03-16_nanoparticles_versus_dendritic_cells_as_vehicles_to_deliver_mRNA_encoding_multipe_epitopes_for_immunotherapy-Gene_&_Cell_Therapy_page_numbers.json

2.4K

3.9K

2020-06-22_nanotechnology_for_COVID-19-therapeutics_and_vaccine_research-acsnano.0c04006_page_numbers.json

369.3K

3.4K

2020-07-02_lipid_nanoparticle_technology_for_therapeutic_gene_regulation_in_the_liver-1-s2.0-S0169409X20300727-main_page_numbers.json

2.6K

2020-07-03_a_brief_review_on_solid_lipid_nanoparticles-part_and_parcel_of_contemporary_drug_delivery_system-d0ra03491f_page_numbers.json

474.0B

2020-07-16_nano_drugs-let_the_blood-brain_barrier_no_longer_be_a_barrier-biopharma PEG_page_numbers.json

647.0B

2020-08-04_liposomes_vs. _lipid_nanoparticles-which_is_best_for_drug_delivery-biopharma PEG_page_numbers.json

2.9K

2020-10-23_advances_in_lipid_nanoparticles_for_mRNA-based_cancer_immunotherapy-fchem-08-589959_page_numbers.json

4.1K

2020-10-30_solid_lipid_nanoparticles_for_drug_delivery-pharmacological_and_biopharmaceutical_aspects-fmolb-07-587997_page_numbers.json

12.5K

1.8K

2020-11-16_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v1_02_nr-1_page_numbers.json

17.8K

2020_exocomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_page_numbers.json

17.8K

2020_exosomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_page_numbers.json

2.8K

2021-01-13_ionizable_lipid_nanoparticles_for_in_utero_mRNA_delivery-sciadv.aba1028_page_numbers.json

11.4K

2021-01-20_saudi_medicinal_assessment_report-Pfizer-BioNTech_COVID-19_Vaccine_page_numbers.json

4.3K

2021-02-02_lipid_nanoparticles_as_delivery_systems_for_RNA-based_vaccines-pharmaceutics-13-00206-v3_page_numbers.json

636.0B

2021-02-09_Lipidnanopartikel_in_COVID-19-Impfung-PEG_und _ihr _allergenes_Potenzial_in_Impfstoffen_page_numbers.json

965.0B

2021-02-11_Nanopartikel_in_mRNA-Impfstoffen-PTAheute_page_numbers.json

311.0B

2021-02-11_SM-102_amino_lipid_product_information_page_numbers.json

13.8K

2021-02-12_Comirnaty-report_on_the_deliberation_results-pharmaceutical_evaluatiob_division_page_numbers.json

4.2K

2021-02-13_nanomedicine_for_COVID-19_the_role_of_nanotechnology_in_the_treatment_and_diagnosis_of_COVID-19_page_numbers.json

479.0B

2021-03-04_editorial-lipid_nanoparticles_as_a_novel_strategy_to_deliver_bioactive_molecules_page_numbers.json

1.3K

2021-03-06_without_these_lipid_shells,_there_would_be_no_mRNA_vaccines_for_COVID-19_page_numbers.json

1.3K

2021-03_Vaccine_development_for_coronavirus_SARS-CoV-2_disease-lipid_nanoparticles-IJRSI_page_numbers.json

4.9K

2021-04-03_the_mRNA-LNP_platform’s_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory_page_numbers.json

4.8K

2021-04-08_lipd-based_nanoparticles_in_the_clinic_and_clinical_trials_from_cancer_nanomedicine_to_COVID-19_vaccines-09-00359_page_numbers.json

3.0K

2021-04-11_Nanotechnologie_der_Covid-19-Vakzinen-Pharmazeutische Zeitung_page_numbers.json

1.6K

2021-04-24_future_considerations_for_the_mRNA-lipid_nanoparticle_vaccine_platform_page_numbers.json

1.8K

2021-05-18_impact_of_lipid_nanparticle_size_on_mRNA_vaccine_immunogenicity-1-s2.0-S0168365921002376-main_page_numbers.json

1.6K

2021-05-28_antiphospholipid_antibodies_and_risk_of_post-COVID-19_vaccination_thrombophilia-The_straw_that_breaks_the_camel’s_back_page_numbers.json

647.0B

2021-05-28_wie_gefährlich_sind_Lipidnanopartikel_in_mRNA-Impfstoffen-schiftl_Anfrage_bayerischer_Landtag-18_0016664_page_numbers.json

975.0B

2021-06-02_gene_therapy_avenues_and_COVID-19-vaccines-s41435-021-00136-6_page_numbers.json

12.1K

2021-06-04_COVID-19_mRNA_Vaccine_BNT162b2_UKPAR_PFIZER_BIONTECH_ext_of_indication_page_numbers.json

647.0B

2021-06-11_overview_of_mRNA-lipid_nanoparticle_covid-19_vaccines-biopharma-PEG_page_numbers.json

479.0B

2021-06-14_Protein_Nanopartikel_Vakzine-BG-Kliniken_page_numbers.json

5.8K

2021-06-28_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_page_numbers.json

311.0B

2021-07-23_ALC-0159-lipid-N-2010_TDS_rev1_page_numbers.json

311.0B

2021-07-23_ALC-0315-lipid-N-1020_TDS_rev1a_page_numbers.json

311.0B

2021-07-30_Lipid_Nanopartikel_ALC-0159_product_information-item_number_34336_page_numbers.json

2.6K

2021-08-11_ionization_and_structural_properties_of_mRNA_lipid_nanoparticles_influence_expression_in_intramuscular_and_intravascular_administration-s42003-021-02441-2_page_numbers.json

1.3K

2021-08-24_ALC-0159_Lipid-Nanopartikel-saety_data_sheet-34336m_page_numbers.json

9.1K

2021-08_novel_lipid_nanoparticle_provides_potent_SARS-CoV2_mRNA _vaccine_at_low_dose_with_low_local_reactogenicity,_high_thermostability_and_limited_systemic_biosdistribution_page_numbers.json

1.9K

2021-09-15_SM-102_amino_lipid_safety_data_sheet_page_numbers.json

647.0B

2021-10-09_lipid_nanoparticles_for_drug_and_vaccine_delivery-Biopharma PEG_page_numbers.json

4.8K

2021-10-26_lipid_nanoparticle_drug_delivery_systems-recent_advances_in_the_treatment_of_skin_disorders-pharmaceuticals-14-01083-v2_page_numbers.json

5.1K

2021-11-08_summary_basis_for_regulatory_action-Comirnaty_page_numbers.json

2.1K

2021-12-07_Pfizer_safety_data_sheet-PF00092-lipid_nanoparticles_MTR_PFEM_EN_page_numbers.json

1.9K

2021-12-14_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v2 (104a-pf00161-mtr-pfem-en-002)_page_numbers.json

815.0B

2021-12-17_potential_implications_of_lipid_nanoparticles_in_the_pathogenesis_of_myocarditis_associated_with_the_use_of_mRNA_vaccines_against_SARS-CoV-2-1-s2.0-S2589936821000839-main_page_numbers.json

2.7K

2021-12-17_the_mRNA-LNP_platform's_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory-CellPress-article_page_numbers.json

7.0K

2021-12-27_Rechtsgutachten_zur_Strafbarkeit_der_Impfung_nach_95 AMG-Beate Bahner_page_numbers.json

311.0B

2021-12_lasting_impact_of_lipid_nanoparticles-s41578-021-00398-6_page_numbers.json

3.0K

2021-12_lipid_nanoparticles_for_mRNA_delivery-review-s41578-021-00358-0_page_numbers.json

479.0B

2021-12_replication_of_SARS-CoV-2_in_adipose_tissue_determines_organ_and_systemic_lipid_metabolism_in_hamsters_and_humans-1-s2.0-S1550413121006215-main_page_numbers.json

479.0B

2021-BioNTech_factsheet_BNT162b2_manufacturing_process_&_ingredients_page_numbers.json

3.9K

2022-01-08_Anti-PEG_antibodies_boosted_in_humans_by_SARS-CoV-2_lipid_nanoparticle_mRNA_vaccine-22268953v1.full_page_numbers.json

2.7K

2022-01-11_non-viral_delivery_of_RNA_gene_therapy_to_the_central_nervous_system-Hauck-JournalArticle-2022_page_numbers.json

1.3K

2022-01-16_Lipid_Nanoparticles_kill_80_percent_of_mice_in_PubMed_Study-thedesertreview_page_numbers.json

1.8K

2022-01-26_biodistribution_and_non-linear_gene_expression_of_mRNA_LNPs_affected_by_delivery_route_and_particle_size_page_numbers.json

1.3K

2022-02-16_BIONTECH_Antwort_an_Pathologie-Konferenz_page_numbers.json

8.4K

2022-02-28_complaint_lawsuit_against_Moderna_for_patent_infringement-lipid_nanoparticles_page_numbers.json

2.6K

2022-05-09_the_clinical_progress_of_mRNA_vaccines_and_immunotherapies-s41587-022-01294-2_page_numbers.json

815.0B

2022-05-19_why_lipid_nanoparticles_are_the_future_of_gene_therapy_and_what_needs_to_happen_next_page_numbers.json

10.7K

2022-05-24_lipid_nanoparticle_compositions_and_methods_for_mRNA_delivery-patent_no_11-338-044-B2_page_numbers.json

2.9K

2022-07-03_the_role_of_lipid_components_in_lipid_nanoparticles_for_vaccines_and_gene_therapy_page_numbers.json

1.6K

2022-07_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.)_page_numbers.json

3.9K

2022-09-02_pre-exposure_to_mRNA-LNP_inhibits_adaptive_immune_responses_and_alters_innate_immune_fitness_in_an_inheritable_fashion-journal.ppat.1010830_page_numbers.json

1.8K

2022-09-09_psychotropic_drugs_interaction_with_the_lipid_nanoparticle_of_COVID-19_mRNA_therapeutics-fphar-13-995481_page_numbers.json

3.5K

2022-10_delivery_of_RNAs_to_specific_organs_by_lipid_nanoparticles_for_gene_therapy-pharmaceutics-14-02129_page_numbers.json

7.1K

2022-12-22_lipid_nanoparticle_composition_drives_mRNA_delivery_to_the_placenta-521490v1.full_page_numbers.json

4.3K

2022_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.) - Beste Gruesse_page_numbers.json

2.3K

2023-01-02_relative_lethality_of_covid-19_vaccines-who_is_measuring_the_casualties-Geoff Pain PhD_page_numbers.json

5.2K

2023-01-26_chemical-physical_criticality_and_toxicological_potential_of_lipid_nanomaterials_contained_in_a_COVID-19_mRNA_vaccine_page_numbers.json

815.0B

2023-02-24_biontech-impfstoff_kein polydispersitätstest_vom paul-ehrlich-Berliner Zeitung_page_numbers.json

802.0B

2023-03-02_lipid_nanoparticles_highly_effective_in_gene_therapy-Hokkaido University_page_numbers.json

5.3K

2023-03-08_ionizable_lipid_nanoparticles_for_in_vivo_mRNA_delivery_to_the_placenta_during_pregnancy-nihms-1878359_page_numbers.json

5.8K

2023-04-01_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_page_numbers.json

2.8K

2023-10-23_apparent_cytotoxicity_and_intrinsic_cytotoxitiy_of_lipid_nanomaterials_contained_in_a_COVID-19-mRNA_vaccine-07102023_R1-4_page_numbers.json

124.3K

Gene_Therapy-tools_and_potential_applications-Francisco Martin Molina_page_numbers.json

1.1K

LP0008-LNO-0315-material_safety_data_sheet-msds-LP008.-for_research_use_only_page_numbers.json

311.0B

LP002-ALC-0315-lipid_nanoparticle-for_research_use_only_page_numbers.json

1.1K

LP002-ALC-0315-material_safety_data_sheet_page_numbers.json

311.0B

LP003-ALC-0159-PEG-lipid_conjugate-for_research_use_only_page_numbers.json

1.1K

LP003-ALC-0159_material_safety_data_sheet-msds-LP003_page_numbers.json

311.0B

LP008-LNP-0315_lipid_nanoparticle-for_research_use_only_page_numbers.json

3.9K

Pfizer-report_Japanese-government_page_numbers.json

4.7K

Toxicological Concerns Related to Nanoscale Drug Delivery Systems_page_numbers.json

479.0B

Transfektion_page_numbers.json

1.3K

biodistribution_of_Pfizer_Lipid_Nano_Particles-Byram Bridle_page_numbers.json

815.0B

transfection-PEG_liposome_transfection-invivotransfection.com_page_numbers.json

647.0B

transfection-in_vivo-invivotransfection.com_page_numbers.json

815.0B

transfection-lipid-based_transfection-invivotransfection.com_page_numbers.json

647.0B

transfection-nanoparticle_transfection-invivotransfection.com_page_numbers.json

815.0B

what_is_cationic_lipid_transfection-thermo fisher scientific_page_numbers.json

132 files

PDF

BACK

711.1K

0000-lipid-nanoparticles.pdf

1.0M

1989-08_cationic_liposome-mediated_RNA_transfection-6077.full.pdf

350.7K

2005-02_the role_of_plasmid_constructs_containing_the_SV40_DNA_nuclear-targeting_sequence_in_cationic_lipid-mediated_DNA_delivery (Circular and Molecular Biology Letters - Vol10_p203.pdf

336.9K

2006-04-14_toxicity_of_cationic_lipids_and_cationic_polymers_in_gene_delivery-journal of controlled release-markiert.pdf

235.2K

2007-08_Cationic_lipids_used_in_non-viral_gene_delivery_systems-article1381164572_Uddin.pdf

3.3M

2008_Nanotechnologie_in_Arzneimitteln_und_Medizinprodukten-Bruno Gander-Institute of Pharmaceutical Sciences-ETH Zürich.pdf

454.6K

2010-06-11_the_systemic_toxicity_of_positively_charged _lipid_nanoparticles_and_the_role_of_Toll-like_receptor_4_in_immune_activation.pdf

279.4K

2011-02_nanoparticulate_drug_delivery_in_pregnancy_placental_passage_and_fetal_exposure.pdf

743.3K

2011_transport_of_nanoparticles_through_the_placental_barrier.pdf

1.2M

2012-02-21_accumulation_of_nanocarriers_in_the_ovary-a_neglected_toxicity_risk.pdf

4.1M

2012-10-18_composite_magnetic_nanoparticle_drug_delivery_system-US-Patent_20120265001A1.pdf

1.2M

2014-01_emerging_research_and_clinical_developement_trends_of_liposome_and_lipid_nanoparticle_drug_delivery_systems-nihms-577214.pdf

1.9M

2014-09-19_mRNA-based_therapeutics-developing_a_new_class_of_drugs-Sahin2014mRNAreview.pdf

30.0M

2014_advances_in_genetics-non_viral_vectors_for_gene_therapy-lipid- and_polymer-based_gene_transfer-volume 88-Huang, Leaf_ Liu, Dexi_ Wagner, Ernst - Academic Press,Elsevier.pdf

2.7M

2014_nanoparticles_and_the_immune_system-safety_and_effects-Diana Boraschi and Albert Duschl (Eds.)-Academic Press.pdf

1.7M

2015-03_engeneering_of_lipid_nanoparticles_for_advanced_drug_delivery.pdf

7.7M

2015_non-viral_vectors_for_gene_therapy-physical_methods_and_medical_translation, Volume 89-Academic Press - Advances in Genetics - Leaf Huang, Dexi Liu, Ernst Wagner.pdf

4.9M

2016-08-11_lipid_nanoparticles_and_uses_thereof-patent_WO2016123864A1.pdf

581.1K

2016-08-31_lipid_nanoparticles_for_gene_delivery-nihms812782.pdf

895.6K

2016-09-13_Ego,_ambition,_and_turmoil-Inside_one_of_biotech's_most_secretive_startups-Statnews.pdf

2.5M

2016-10-31_toxicity_of_graphene-family_nanoparticles-a_general_review_of_the_origins_and_mechanisms.pdf

2.8M

2016_nanoparticle_transport_across_the_placental_barrier-pushing_the_field_forward.pdf

3.7M

2017-05_development_and_characterization_of_microencapsulated_nanoparticle_systems_for_oral_vaccination_by_Protein-Antigens-Dissertation.pdf

1.8M

2017-07_lipid_nanoparticle_systems_for_enabling_gene_therapies.pdf

945.0K

2018-04-05_correlation_of_the_cytotoxic_effects_of_cationic_lipids_with_their_headgroups.pdf

725.7K

2018-04-11_potential_adverse_effects_of_nanoparticles_in_the_reproductive_system-ijn-170723.pdf

1.6M

2018-06-06_a_novel_amino_lipid_series_for_mRNA_delivery-improved_endosomal_escape_and_sustained_pharmacology_and_safety_in_non-human_primates.pdf

6.8M

2018-1-16_liposomes_and_lipid_nanoparticles_as_delivery_vehicles_for_personalized_medicine.pdf

391.5K

2019-01-08_gene_therapy_in_the_era_of_nanotechnology-a_review_of_current_data-JCPCR-10-00380.pdf

3.1M

2019-046-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main.pdf

1.4M

2019-05-07_lipid_nanoparticles_for_deliveery_of_therapeutic_RNA_oligonucleotides-moss2019.pdf

1.8M

2019-06-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main.pdf

3.7M

2019-08-09_Lipid_Nanoparticle_Technology_for_Clinical_Translation_of_siRNA_Therapeutics-Kulkarni et al-markiert.pdf

965.9K

2019-08-27_biologisches_Gefahrenpotenzial_von_Nanopartikeln_untersucht.pdf

56.4K

2020-01-05_Lipid_Nanoparticles_in_COVID-19_vaccines-letter_to_Peter Marks-Aaron Siri.pdf

2.4M

2020-02-20_nanomedicines_to_deliver_mRNA-state_of_the_art_and_future_perspectives-nanomaterials-10-00364-v2.pdf

3.7M

2020-03-16_lipid_nanoparticle_technology_for_clinical_translation_of_siRNA_therapeutics-ar9b00368 1..10.pdf

3.2M

2020-03-16_nanoparticles_versus_dendritic_cells_as_vehicles_to_deliver_mRNA_encoding_multipe_epitopes_for_immunotherapy-Gene_&_Cell_Therapy.pdf

408.6K

2020-04-22_self-amplifying_RNA_SARS-CoV-2_lipid_nanoparticle_vaccine_induces_equivalent_preclinical_antibody_titers_and_viral_neutralization_to_recovered_COVID-19_patients-055608v1.full.pdf

10.3M

2020-06-22_nanotechnology_for_COVID-19-therapeutics_and_vaccine_research-acsnano.0c04006.pdf

21.2M

2.1M

2020-07-02_lipid_nanoparticle_technology_for_therapeutic_gene_regulation_in_the_liver-1-s2.0-S0169409X20300727-main.pdf

1.2M

2020-07-03_a_brief_review_on_solid_lipid_nanoparticles-part_and_parcel_of_contemporary_drug_delivery_system-d0ra03491f.pdf

386.6K

2020-07-16_nano_drugs-let_the_blood-brain_barrier_no_longer_be_a_barrier-biopharma PEG.pdf

623.8K

2020-08-04_liposomes_vs. _lipid_nanoparticles-which_is_best_for_drug_delivery-biopharma PEG.pdf

1.8M

2020-10-23_advances_in_lipid_nanoparticles_for_mRNA-based_cancer_immunotherapy-fchem-08-589959.pdf

4.0M

2020-10-30_solid_lipid_nanoparticles_for_drug_delivery-pharmacological_and_biopharmaceutical_aspects-fmolb-07-587997.pdf

1.4M

55.6K

2020-11-16_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v1_02_nr-1.pdf

5.6M

2020_exocomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01.pdf

3.8M

2020_exosomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01.pdf

1.3M

2021-01-13_ionizable_lipid_nanoparticles_for_in_utero_mRNA_delivery-sciadv.aba1028.pdf

2.0M

2021-01-20_saudi_medicinal_assessment_report-Pfizer-BioNTech_COVID-19_Vaccine.pdf

9.4M

2021-02-02_lipid_nanoparticles_as_delivery_systems_for_RNA-based_vaccines-pharmaceutics-13-00206-v3.pdf

302.1K

2021-02-09_Lipidnanopartikel_in_COVID-19-Impfung-PEG_und _ihr _allergenes_Potenzial_in_Impfstoffen.pdf

885.0K

2021-02-11_Nanopartikel_in_mRNA-Impfstoffen-PTAheute.pdf

168.7K

2021-02-11_SM-102_amino_lipid_product_information.pdf

2.0M

2021-02-12_Comirnaty-report_on_the_deliberation_results-pharmaceutical_evaluatiob_division.pdf

1.0M

2021-02-13_nanomedicine_for_COVID-19_the_role_of_nanotechnology_in_the_treatment_and_diagnosis_of_COVID-19.pdf

511.3K

2021-03-04_editorial-lipid_nanoparticles_as_a_novel_strategy_to_deliver_bioactive_molecules.pdf

3.9M

2021-03-06_without_these_lipid_shells,_there_would_be_no_mRNA_vaccines_for_COVID-19.pdf

665.0K

2021-03_Vaccine_development_for_coronavirus_SARS-CoV-2_disease-lipid_nanoparticles-IJRSI.pdf

852.1K

2021-04-03_the_mRNA-LNP_platform’s_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory.pdf

13.5M

2021-04-08_lipd-based_nanoparticles_in_the_clinic_and_clinical_trials_from_cancer_nanomedicine_to_COVID-19_vaccines-09-00359.pdf

4.0M

2021-04-11_Nanotechnologie_der_Covid-19-Vakzinen-Pharmazeutische Zeitung.pdf

1,002.6K

2021-04-24_future_considerations_for_the_mRNA-lipid_nanoparticle_vaccine_platform.pdf

4.0M

2021-05-18_impact_of_lipid_nanparticle_size_on_mRNA_vaccine_immunogenicity-1-s2.0-S0168365921002376-main.pdf

3.0M

2021-05-28_antiphospholipid_antibodies_and_risk_of_post-COVID-19_vaccination_thrombophilia-The_straw_that_breaks_the_camel’s_back.pdf

484.4K

2021-05-28_wie_gefährlich_sind_Lipidnanopartikel_in_mRNA-Impfstoffen-schiftl_Anfrage_bayerischer_Landtag-18_0016664.pdf

450.8K

2021-06-02_gene_therapy_avenues_and_COVID-19-vaccines-s41435-021-00136-6.pdf

4.1M

2021-06-04_COVID-19_mRNA_Vaccine_BNT162b2_UKPAR_PFIZER_BIONTECH_ext_of_indication.pdf

461.6K

2021-06-11_overview_of_mRNA-lipid_nanoparticle_covid-19_vaccines-biopharma-PEG.pdf

533.5K

2021-06-14_Protein_Nanopartikel_Vakzine-BG-Kliniken.pdf

14.2M

2021-06-28_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996.pdf

297.9K

2021-07-23_ALC-0159-lipid-N-2010_TDS_rev1.pdf

159.1K

2021-07-23_ALC-0315-lipid-N-1020_TDS_rev1a.pdf

177.0K

2021-07-30_Lipid_Nanopartikel_ALC-0159_product_information-item_number_34336.pdf

2.8M

2021-08-11_ionization_and_structural_properties_of_mRNA_lipid_nanoparticles_influence_expression_in_intramuscular_and_intravascular_administration-s42003-021-02441-2.pdf

127.2K

2021-08-24_ALC-0159_Lipid-Nanopartikel-saety_data_sheet-34336m.pdf

3.5M

2021-08_novel_lipid_nanoparticle_provides_potent_SARS-CoV2_mRNA _vaccine_at_low_dose_with_low_local_reactogenicity,_high_thermostability_and_limited_systemic_biosdistribution.pdf

160.4K

2021-09-15_SM-102_amino_lipid_safety_data_sheet.pdf

553.1K

2021-10-09_lipid_nanoparticles_for_drug_and_vaccine_delivery-Biopharma PEG.pdf

1.5M

2021-10-26_lipid_nanoparticle_drug_delivery_systems-recent_advances_in_the_treatment_of_skin_disorders-pharmaceuticals-14-01083-v2.pdf

316.6K

2021-11-08_summary_basis_for_regulatory_action-Comirnaty.pdf

248.1K

2021-12-07_Pfizer_safety_data_sheet-PF00092-lipid_nanoparticles_MTR_PFEM_EN.pdf

237.4K

2021-12-14_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v2 (104a-pf00161-mtr-pfem-en-002).pdf

878.0K

2021-12-17_potential_implications_of_lipid_nanoparticles_in_the_pathogenesis_of_myocarditis_associated_with_the_use_of_mRNA_vaccines_against_SARS-CoV-2-1-s2.0-S2589936821000839-main.pdf

2.9M

2021-12-17_the_mRNA-LNP_platform's_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory-CellPress-article.pdf

352.4K

2021-12-27_Rechtsgutachten_zur_Strafbarkeit_der_Impfung_nach_95 AMG-Beate Bahner.pdf

241.3K

2021-12_lasting_impact_of_lipid_nanoparticles-s41578-021-00398-6.pdf

3.8M

2021-12_lipid_nanoparticles_for_mRNA_delivery-review-s41578-021-00358-0.pdf

153.8K

2021-12_replication_of_SARS-CoV-2_in_adipose_tissue_determines_organ_and_systemic_lipid_metabolism_in_hamsters_and_humans-1-s2.0-S1550413121006215-main.pdf

688.4K

2021-BioNTech_factsheet_BNT162b2_manufacturing_process_&_ingredients.pdf

759.2K

2022-01-08_Anti-PEG_antibodies_boosted_in_humans_by_SARS-CoV-2_lipid_nanoparticle_mRNA_vaccine-22268953v1.full.pdf

2.4M

2022-01-11_non-viral_delivery_of_RNA_gene_therapy_to_the_central_nervous_system-Hauck-JournalArticle-2022.pdf

2.2M

2022-01-16_Lipid_Nanoparticles_kill_80_percent_of_mice_in_PubMed_Study-thedesertreview.pdf

1.4M

2022-01-26_biodistribution_and_non-linear_gene_expression_of_mRNA_LNPs_affected_by_delivery_route_and_particle_size.pdf

169.9K

2022-02-16_BIONTECH_Antwort_an_Pathologie-Konferenz.pdf

330.0K

2022-02-28_complaint_lawsuit_against_Moderna_for_patent_infringement-lipid_nanoparticles.pdf

1.6M

2022-05-09_the_clinical_progress_of_mRNA_vaccines_and_immunotherapies-s41587-022-01294-2.pdf

3.0M

2022-05-19_why_lipid_nanoparticles_are_the_future_of_gene_therapy_and_what_needs_to_happen_next.pdf

4.1M

2022-05-24_lipid_nanoparticle_compositions_and_methods_for_mRNA_delivery-patent_no_11-338-044-B2.pdf

3.7M

2022-07-03_the_role_of_lipid_components_in_lipid_nanoparticles_for_vaccines_and_gene_therapy.pdf

1.9M

2022-07_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.).pdf

2.3M

2022-09-02_pre-exposure_to_mRNA-LNP_inhibits_adaptive_immune_responses_and_alters_innate_immune_fitness_in_an_inheritable_fashion-journal.ppat.1010830.pdf

912.9K

2022-09-09_psychotropic_drugs_interaction_with_the_lipid_nanoparticle_of_COVID-19_mRNA_therapeutics-fphar-13-995481.pdf

1.1M

2022-10_delivery_of_RNAs_to_specific_organs_by_lipid_nanoparticles_for_gene_therapy-pharmaceutics-14-02129.pdf

1.1M

2022-12-22_lipid_nanoparticle_composition_drives_mRNA_delivery_to_the_placenta-521490v1.full.pdf

2.7M

2022_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.) - Beste Gruesse.pdf

3.2M

2023-01-02_relative_lethality_of_covid-19_vaccines-who_is_measuring_the_casualties-Geoff Pain PhD.pdf

4.3M

2023-01-26_chemical-physical_criticality_and_toxicological_potential_of_lipid_nanomaterials_contained_in_a_COVID-19_mRNA_vaccine.pdf

5.2M

2023-02-24_biontech-impfstoff_kein polydispersitätstest_vom paul-ehrlich-Berliner Zeitung.pdf

505.2K

2023-03-02_lipid_nanoparticles_highly_effective_in_gene_therapy-Hokkaido University.pdf

2.7M

2023-03-08_ionizable_lipid_nanoparticles_for_in_vivo_mRNA_delivery_to_the_placenta_during_pregnancy-nihms-1878359.pdf

14.2M

2023-04-01_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996.pdf

1.4M

2023-10-23_apparent_cytotoxicity_and_intrinsic_cytotoxitiy_of_lipid_nanomaterials_contained_in_a_COVID-19-mRNA_vaccine-07102023_R1-4.pdf

27.3M

Gene_Therapy-tools_and_potential_applications-Francisco Martin Molina.pdf

109.9K

LP0008-LNO-0315-material_safety_data_sheet-msds-LP008.-for_research_use_only.pdf

431.3K

LP002-ALC-0315-lipid_nanoparticle-for_research_use_only.pdf

109.8K

LP002-ALC-0315-material_safety_data_sheet.pdf

466.9K

LP003-ALC-0159-PEG-lipid_conjugate-for_research_use_only.pdf

109.8K

LP003-ALC-0159_material_safety_data_sheet-msds-LP003.pdf

58.9K

LP008-LNP-0315_lipid_nanoparticle-for_research_use_only.pdf

18.9M

Pfizer-report_Japanese-government.pdf

640.0K

Toxicological Concerns Related to Nanoscale Drug Delivery Systems.pdf

366.9K

Transfektion.pdf

588.4K

biodistribution_of_Pfizer_Lipid_Nano_Particles-Byram Bridle.pdf

442.5K

transfection-PEG_liposome_transfection-invivotransfection.com.pdf

131.5K

transfection-in_vivo-invivotransfection.com.pdf

261.5K

transfection-lipid-based_transfection-invivotransfection.com.pdf

74.6K

transfection-nanoparticle_transfection-invivotransfection.com.pdf

192.5K

what_is_cationic_lipid_transfection-thermo fisher scientific.pdf

4 files

PDF WITH TEXT

BACK

54.6K

0000-lipid-nanoparticles_text.pdf

4.3M

2016-08-11_lipid_nanoparticles_and_uses_thereof-patent_WO2016123864A1_text.pdf

5.0M

2022-05-24_lipid_nanoparticle_compositions_and_methods_for_mRNA_delivery-patent_no_11-338-044-B2_text.pdf

2.1M

Pfizer-report_Japanese-government_text.pdf

132 files

SINGLE PAGE PROCESSED JP2 ZIP

BACK

72.9K

0000-lipid-nanoparticles_jp2.zip

11.5M

1989-08_cationic_liposome-mediated_RNA_transfection-6077.full_jp2.zip

5.7M

2005-02_the role_of_plasmid_constructs_containing_the_SV40_DNA_nuclear-targeting_sequence_in_cationic_lipid-mediated_DNA_delivery (Circular and Molecular Biology Letters - Vol10_p203_jp2.zip

7.2M

2006-04-14_toxicity_of_cationic_lipids_and_cationic_polymers_in_gene_delivery-journal of controlled release-markiert_jp2.zip

8.6M

2007-08_Cationic_lipids_used_in_non-viral_gene_delivery_systems-article1381164572_Uddin_jp2.zip

6.1M

2008_Nanotechnologie_in_Arzneimitteln_und_Medizinprodukten-Bruno Gander-Institute of Pharmaceutical Sciences-ETH Zürich_jp2.zip

6.0M

2010-06-11_the_systemic_toxicity_of_positively_charged _lipid_nanoparticles_and_the_role_of_Toll-like_receptor_4_in_immune_activation_jp2.zip

13.1M

2011-02_nanoparticulate_drug_delivery_in_pregnancy_placental_passage_and_fetal_exposure_jp2.zip

7.4M

2011_transport_of_nanoparticles_through_the_placental_barrier_jp2.zip

14.1M

2012-02-21_accumulation_of_nanocarriers_in_the_ovary-a_neglected_toxicity_risk_jp2.zip

19.6M

2012-10-18_composite_magnetic_nanoparticle_drug_delivery_system-US-Patent_20120265001A1_jp2.zip

25.4M

2014-01_emerging_research_and_clinical_developement_trends_of_liposome_and_lipid_nanoparticle_drug_delivery_systems-nihms-577214_jp2.zip

16.2M

2014-09-19_mRNA-based_therapeutics-developing_a_new_class_of_drugs-Sahin2014mRNAreview_jp2.zip

178.0M

2014_advances_in_genetics-non_viral_vectors_for_gene_therapy-lipid- and_polymer-based_gene_transfer-volume 88-Huang, Leaf_ Liu, Dexi_ Wagner, Ernst - Academic Press,Elsevier_jp2.zip

50.2M

2014_nanoparticles_and_the_immune_system-safety_and_effects-Diana Boraschi and Albert Duschl (Eds.)-Academic Press_jp2.zip

22.7M

2015-03_engeneering_of_lipid_nanoparticles_for_advanced_drug_delivery_jp2.zip

114.0M

2015_non-viral_vectors_for_gene_therapy-physical_methods_and_medical_translation, Volume 89-Academic Press - Advances in Genetics - Leaf Huang, Dexi Liu, Ernst Wagner_jp2.zip

32.4M

2016-08-11_lipid_nanoparticles_and_uses_thereof-patent_WO2016123864A1_jp2.zip

10.7M

2016-08-31_lipid_nanoparticles_for_gene_delivery-nihms812782_jp2.zip

9.4M

2016-09-13_Ego,_ambition,_and_turmoil-Inside_one_of_biotech's_most_secretive_startups-Statnews_jp2.zip

37.9M

2016-10-31_toxicity_of_graphene-family_nanoparticles-a_general_review_of_the_origins_and_mechanisms_jp2.zip

13.6M

2016_nanoparticle_transport_across_the_placental_barrier-pushing_the_field_forward_jp2.zip

92.4M

2017-05_development_and_characterization_of_microencapsulated_nanoparticle_systems_for_oral_vaccination_by_Protein-Antigens-Dissertation_jp2.zip

6.2M

2017-07_lipid_nanoparticle_systems_for_enabling_gene_therapies_jp2.zip

10.4M

2018-04-05_correlation_of_the_cytotoxic_effects_of_cationic_lipids_with_their_headgroups_jp2.zip

11.1M

2018-04-11_potential_adverse_effects_of_nanoparticles_in_the_reproductive_system-ijn-170723_jp2.zip

7.7M

2018-06-06_a_novel_amino_lipid_series_for_mRNA_delivery-improved_endosomal_escape_and_sustained_pharmacology_and_safety_in_non-human_primates_jp2.zip

4.0M

2018-1-16_liposomes_and_lipid_nanoparticles_as_delivery_vehicles_for_personalized_medicine_jp2.zip

1.2M

2019-01-08_gene_therapy_in_the_era_of_nanotechnology-a_review_of_current_data-JCPCR-10-00380_jp2.zip

16.8M

2019-046-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_jp2.zip

11.6M

2019-05-07_lipid_nanoparticles_for_deliveery_of_therapeutic_RNA_oligonucleotides-moss2019_jp2.zip

16.8M

2019-06-17_emerging_trends_in_the_novel_drug_delievry_approaches_for_the_treatment_of_lung_cancer-1_s2.0_S0009279719307653_main_jp2.zip

8.3M

2019-08-09_Lipid_Nanoparticle_Technology_for_Clinical_Translation_of_siRNA_Therapeutics-Kulkarni et al-markiert_jp2.zip

1.8M

2019-08-27_biologisches_Gefahrenpotenzial_von_Nanopartikeln_untersucht_jp2.zip

610.4K

2020-01-05_Lipid_Nanoparticles_in_COVID-19_vaccines-letter_to_Peter Marks-Aaron Siri_jp2.zip

28.0M

2020-02-20_nanomedicines_to_deliver_mRNA-state_of_the_art_and_future_perspectives-nanomaterials-10-00364-v2_jp2.zip

8.3M

2020-03-16_lipid_nanoparticle_technology_for_clinical_translation_of_siRNA_therapeutics-ar9b00368 1..10_jp2.zip

9.2M

2020-03-16_nanoparticles_versus_dendritic_cells_as_vehicles_to_deliver_mRNA_encoding_multipe_epitopes_for_immunotherapy-Gene_&_Cell_Therapy_jp2.zip

5.8M

2020-04-22_self-amplifying_RNA_SARS-CoV-2_lipid_nanoparticle_vaccine_induces_equivalent_preclinical_antibody_titers_and_viral_neutralization_to_recovered_COVID-19_patients-055608v1.full_jp2.zip

46.3M

2020-06-22_nanotechnology_for_COVID-19-therapeutics_and_vaccine_research-acsnano.0c04006_jp2.zip

502.1M

18.2M

2020-07-02_lipid_nanoparticle_technology_for_therapeutic_gene_regulation_in_the_liver-1-s2.0-S0169409X20300727-main_jp2.zip

9.5M

2020-07-03_a_brief_review_on_solid_lipid_nanoparticles-part_and_parcel_of_contemporary_drug_delivery_system-d0ra03491f_jp2.zip

1.8M

2020-07-16_nano_drugs-let_the_blood-brain_barrier_no_longer_be_a_barrier-biopharma PEG_jp2.zip

2.1M

2020-08-04_liposomes_vs. _lipid_nanoparticles-which_is_best_for_drug_delivery-biopharma PEG_jp2.zip

12.0M

2020-10-23_advances_in_lipid_nanoparticles_for_mRNA-based_cancer_immunotherapy-fchem-08-589959_jp2.zip

18.1M

2020-10-30_solid_lipid_nanoparticles_for_drug_delivery-pharmacological_and_biopharmaceutical_aspects-fmolb-07-587997_jp2.zip

26.3M

3.7M

2020-11-16_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v1_02_nr-1_jp2.zip

50.7M

2020_exocomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_jp2.zip

50.7M

2020_exosomes_and_lipid_nanoparticles-the_future_of_targeted_drug_delivery-FULLTEXT01_jp2.zip

12.4M

2021-01-13_ionizable_lipid_nanoparticles_for_in_utero_mRNA_delivery-sciadv.aba1028_jp2.zip

24.0M

2021-01-20_saudi_medicinal_assessment_report-Pfizer-BioNTech_COVID-19_Vaccine_jp2.zip

18.7M

2021-02-02_lipid_nanoparticles_as_delivery_systems_for_RNA-based_vaccines-pharmaceutics-13-00206-v3_jp2.zip

2.1M

2021-02-09_Lipidnanopartikel_in_COVID-19-Impfung-PEG_und _ihr _allergenes_Potenzial_in_Impfstoffen_jp2.zip

2.3M

2021-02-11_Nanopartikel_in_mRNA-Impfstoffen-PTAheute_jp2.zip

325.8K

2021-02-11_SM-102_amino_lipid_product_information_jp2.zip

46.9M

2021-02-12_Comirnaty-report_on_the_deliberation_results-pharmaceutical_evaluatiob_division_jp2.zip

19.3M

2021-02-13_nanomedicine_for_COVID-19_the_role_of_nanotechnology_in_the_treatment_and_diagnosis_of_COVID-19_jp2.zip

3.0M

2021-03-04_editorial-lipid_nanoparticles_as_a_novel_strategy_to_deliver_bioactive_molecules_jp2.zip

9.5M

2021-03-06_without_these_lipid_shells,_there_would_be_no_mRNA_vaccines_for_COVID-19_jp2.zip

6.1M

2021-03_Vaccine_development_for_coronavirus_SARS-CoV-2_disease-lipid_nanoparticles-IJRSI_jp2.zip

10.7M

2021-04-03_the_mRNA-LNP_platform’s_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory_jp2.zip

20.0M

2021-04-08_lipd-based_nanoparticles_in_the_clinic_and_clinical_trials_from_cancer_nanomedicine_to_COVID-19_vaccines-09-00359_jp2.zip

17.8M

2021-04-11_Nanotechnologie_der_Covid-19-Vakzinen-Pharmazeutische Zeitung_jp2.zip

5.3M

2021-04-24_future_considerations_for_the_mRNA-lipid_nanoparticle_vaccine_platform_jp2.zip

8.0M

2021-05-18_impact_of_lipid_nanparticle_size_on_mRNA_vaccine_immunogenicity-1-s2.0-S0168365921002376-main_jp2.zip

7.5M

2021-05-28_antiphospholipid_antibodies_and_risk_of_post-COVID-19_vaccination_thrombophilia-The_straw_that_breaks_the_camel’s_back_jp2.zip

1.7M

2021-05-28_wie_gefährlich_sind_Lipidnanopartikel_in_mRNA-Impfstoffen-schiftl_Anfrage_bayerischer_Landtag-18_0016664_jp2.zip

3.5M

2021-06-02_gene_therapy_avenues_and_COVID-19-vaccines-s41435-021-00136-6_jp2.zip

40.2M

2021-06-04_COVID-19_mRNA_Vaccine_BNT162b2_UKPAR_PFIZER_BIONTECH_ext_of_indication_jp2.zip

1.9M

2021-06-11_overview_of_mRNA-lipid_nanoparticle_covid-19_vaccines-biopharma-PEG_jp2.zip

1.2M

2021-06-14_Protein_Nanopartikel_Vakzine-BG-Kliniken_jp2.zip

23.4M

2021-06-28_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_jp2.zip

1.1M

2021-07-23_ALC-0159-lipid-N-2010_TDS_rev1_jp2.zip

1.1M

2021-07-23_ALC-0315-lipid-N-1020_TDS_rev1a_jp2.zip

394.2K

2021-07-30_Lipid_Nanopartikel_ALC-0159_product_information-item_number_34336_jp2.zip

11.0M

2021-08-11_ionization_and_structural_properties_of_mRNA_lipid_nanoparticles_influence_expression_in_intramuscular_and_intravascular_administration-s42003-021-02441-2_jp2.zip

2.5M

2021-08-24_ALC-0159_Lipid-Nanopartikel-saety_data_sheet-34336m_jp2.zip

23.1M

2021-08_novel_lipid_nanoparticle_provides_potent_SARS-CoV2_mRNA _vaccine_at_low_dose_with_low_local_reactogenicity,_high_thermostability_and_limited_systemic_biosdistribution_jp2.zip

4.0M

2021-09-15_SM-102_amino_lipid_safety_data_sheet_jp2.zip

2.4M

2021-10-09_lipid_nanoparticles_for_drug_and_vaccine_delivery-Biopharma PEG_jp2.zip

19.6M

2021-10-26_lipid_nanoparticle_drug_delivery_systems-recent_advances_in_the_treatment_of_skin_disorders-pharmaceuticals-14-01083-v2_jp2.zip

15.4M

2021-11-08_summary_basis_for_regulatory_action-Comirnaty_jp2.zip

4.8M

2021-12-07_Pfizer_safety_data_sheet-PF00092-lipid_nanoparticles_MTR_PFEM_EN_jp2.zip

4.4M

2021-12-14_Pfizer_safety_data_sheet-BioNTech_COVID_19_Vaccine_v2 (104a-pf00161-mtr-pfem-en-002)_jp2.zip

7.4M

2021-12-17_potential_implications_of_lipid_nanoparticles_in_the_pathogenesis_of_myocarditis_associated_with_the_use_of_mRNA_vaccines_against_SARS-CoV-2-1-s2.0-S2589936821000839-main_jp2.zip

20.7M

2021-12-17_the_mRNA-LNP_platform's_lipid_nanoparticle_component_used_in_preclinical_vaccine_studies_is_highly_inflammatory-CellPress-article_jp2.zip

16.1M

2021-12-27_Rechtsgutachten_zur_Strafbarkeit_der_Impfung_nach_95 AMG-Beate Bahner_jp2.zip

764.7K

2021-12_lasting_impact_of_lipid_nanoparticles-s41578-021-00398-6_jp2.zip

33.5M

2021-12_lipid_nanoparticles_for_mRNA_delivery-review-s41578-021-00358-0_jp2.zip

1.9M

2021-12_replication_of_SARS-CoV-2_in_adipose_tissue_determines_organ_and_systemic_lipid_metabolism_in_hamsters_and_humans-1-s2.0-S1550413121006215-main_jp2.zip

2.0M

2021-BioNTech_factsheet_BNT162b2_manufacturing_process_&_ingredients_jp2.zip

20.4M

2022-01-08_Anti-PEG_antibodies_boosted_in_humans_by_SARS-CoV-2_lipid_nanoparticle_mRNA_vaccine-22268953v1.full_jp2.zip

9.2M

2022-01-11_non-viral_delivery_of_RNA_gene_therapy_to_the_central_nervous_system-Hauck-JournalArticle-2022_jp2.zip

3.2M

2022-01-16_Lipid_Nanoparticles_kill_80_percent_of_mice_in_PubMed_Study-thedesertreview_jp2.zip

5.7M

2022-01-26_biodistribution_and_non-linear_gene_expression_of_mRNA_LNPs_affected_by_delivery_route_and_particle_size_jp2.zip

2.8M

2022-02-16_BIONTECH_Antwort_an_Pathologie-Konferenz_jp2.zip

22.4M

2022-02-28_complaint_lawsuit_against_Moderna_for_patent_infringement-lipid_nanoparticles_jp2.zip

15.0M

2022-05-09_the_clinical_progress_of_mRNA_vaccines_and_immunotherapies-s41587-022-01294-2_jp2.zip

1.1M

2022-05-19_why_lipid_nanoparticles_are_the_future_of_gene_therapy_and_what_needs_to_happen_next_jp2.zip

37.6M

2022-05-24_lipid_nanoparticle_compositions_and_methods_for_mRNA_delivery-patent_no_11-338-044-B2_jp2.zip

15.7M

2022-07-03_the_role_of_lipid_components_in_lipid_nanoparticles_for_vaccines_and_gene_therapy_jp2.zip

6.2M

2022-07_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.)_jp2.zip

12.6M

2022-09-02_pre-exposure_to_mRNA-LNP_inhibits_adaptive_immune_responses_and_alters_innate_immune_fitness_in_an_inheritable_fashion-journal.ppat.1010830_jp2.zip

6.5M

2022-09-09_psychotropic_drugs_interaction_with_the_lipid_nanoparticle_of_COVID-19_mRNA_therapeutics-fphar-13-995481_jp2.zip

11.8M

2022-10_delivery_of_RNAs_to_specific_organs_by_lipid_nanoparticles_for_gene_therapy-pharmaceutics-14-02129_jp2.zip

17.3M

2022-12-22_lipid_nanoparticle_composition_drives_mRNA_delivery_to_the_placenta-521490v1.full_jp2.zip

10.8M

2022_pressure-dependent_fouling_behaviour_during_sterile_filtration_of_mRNA-conatining_lipid_nanoparticles (Moderna Inc.) - Beste Gruesse_jp2.zip

3.4M

2023-01-02_relative_lethality_of_covid-19_vaccines-who_is_measuring_the_casualties-Geoff Pain PhD_jp2.zip

16.7M

2023-01-26_chemical-physical_criticality_and_toxicological_potential_of_lipid_nanomaterials_contained_in_a_COVID-19_mRNA_vaccine_jp2.zip

1.2M

2023-02-24_biontech-impfstoff_kein polydispersitätstest_vom paul-ehrlich-Berliner Zeitung_jp2.zip

1.5M

2023-03-02_lipid_nanoparticles_highly_effective_in_gene_therapy-Hokkaido University_jp2.zip

13.6M

2023-03-08_ionizable_lipid_nanoparticles_for_in_vivo_mRNA_delivery_to_the_placenta_during_pregnancy-nihms-1878359_jp2.zip

23.4M

2023-04-01_lipid_nanoparticles─from_liposomes_to_mRNA_vaccine_delivery,_a_landscape_of_research_diversity_and_advancement-acsnano.1c04996_jp2.zip

8.5M

2023-10-23_apparent_cytotoxicity_and_intrinsic_cytotoxitiy_of_lipid_nanomaterials_contained_in_a_COVID-19-mRNA_vaccine-07102023_R1-4_jp2.zip

254.5M

Gene_Therapy-tools_and_potential_applications-Francisco Martin Molina_jp2.zip

1.8M

LP0008-LNO-0315-material_safety_data_sheet-msds-LP008.-for_research_use_only_jp2.zip

457.7K

LP002-ALC-0315-lipid_nanoparticle-for_research_use_only_jp2.zip

1.8M

LP002-ALC-0315-material_safety_data_sheet_jp2.zip

461.5K

LP003-ALC-0159-PEG-lipid_conjugate-for_research_use_only_jp2.zip

1.8M

LP003-ALC-0159_material_safety_data_sheet-msds-LP003_jp2.zip

632.1K

LP008-LNP-0315_lipid_nanoparticle-for_research_use_only_jp2.zip

4.7M

Pfizer-report_Japanese-government_jp2.zip

12.0M

Toxicological Concerns Related to Nanoscale Drug Delivery Systems_jp2.zip

696.4K

Transfektion_jp2.zip

3.4M

biodistribution_of_Pfizer_Lipid_Nano_Particles-Byram Bridle_jp2.zip

1.1M

transfection-PEG_liposome_transfection-invivotransfection.com_jp2.zip

1.1M

transfection-in_vivo-invivotransfection.com_jp2.zip

1.2M

transfection-lipid-based_transfection-invivotransfection.com_jp2.zip

985.3K

transfection-nanoparticle_transfection-invivotransfection.com_jp2.zip

701.5K

what_is_cationic_lipid_transfection-thermo fisher scientific_jp2.zip

1 file

TORRENT

1329 Files
135 Original

SHOW ALL

IN COLLECTIONS

Community Texts

Community Collections

Uploaded by Rodney Corbine on January 7, 2022

Internet Archive Audio

Featured

Top

Images

Featured

Top

Software

Featured

Top

Books

Featured

Top

Video

Featured

Top

Mobile Apps

Browser Extensions

Archive-It Subscription

Save Page Now

lipids

plus-circle Add Review

comment
Reviews

DOWNLOAD OPTIONS

IN COLLECTIONS

SIMILAR ITEMS (based on metadata)

Internet Archive Audio

Featured

Top

Images

Featured

Top

Software

Featured

Top

Books

Featured

Top

Video

Featured

Top

Mobile Apps

Browser Extensions

Archive-It Subscription

Save Page Now

lipids

Bookreader Item Preview

Flag this item for

lipids

plus-circle Add Review comment Reviews

DOWNLOAD OPTIONS

IN COLLECTIONS

SIMILAR ITEMS (based on metadata)

plus-circle Add Review

comment
Reviews